<SEC-DOCUMENT>0001193125-25-125071.txt : 20250522
<SEC-HEADER>0001193125-25-125071.hdr.sgml : 20250522
<ACCEPTANCE-DATETIME>20250522161619
ACCESSION NUMBER:		0001193125-25-125071
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250520
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250522
DATE AS OF CHANGE:		20250522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEVA PHARMACEUTICAL INDUSTRIES LTD
		CENTRAL INDEX KEY:			0000818686
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16174
		FILM NUMBER:		25977366

	BUSINESS ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6944020
		BUSINESS PHONE:		972 (3) 914-8213

	MAIL ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6944020
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d929611d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:teva="http://imetrix.edgar-online.com/20250520" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2025-05-20_to_2025-05-20">TEVA PHARMACEUTICAL INDUSTRIES LTD</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityTaxIdentificationNumber" name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-05-20_to_2025-05-20">00-0000000</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-255">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-05-20_to_2025-05-20">0000818686</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="teva-20250520.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-05-20_to_2025-05-20"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000818686</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-05-20</xbrli:startDate> <xbrli:endDate>2025-05-20</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-266">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported) <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-05-20_to_2025-05-20" format="ixt:datemonthdayyearen" id="ixv-267">May&#160;20, 2025</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-05-20_to_2025-05-20" format="ixt-sec:edgarprovcountryen" id="ixv-268">Israel</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-269">001-16174</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"> <span style=" -sec-ix-hidden:Hidden_dei_EntityTaxIdentificationNumber">Not Applicable</span> </span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-270">124 Dvora HaNevi&#8217;a Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-271">Tel Aviv</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-272">6944020</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2025-05-20_to_2025-05-20" format="ixt-sec:countrynameen" id="ixv-273">Israel</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">+<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-274">972</ix:nonNumeric><span style="white-space:nowrap">-</span> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-275">3-914-8213</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-05-20_to_2025-05-20" format="ixt-sec:boolballotbox" id="ixv-276">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-05-20_to_2025-05-20" format="ixt-sec:boolballotbox" id="ixv-277">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-05-20_to_2025-05-20" format="ixt-sec:boolballotbox" id="ixv-278">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-05-20_to_2025-05-20" format="ixt-sec:boolballotbox" id="ixv-279">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-280">American Depositary Shares, each representing one Ordinary Share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-281">TEVA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-05-20_to_2025-05-20" format="ixt-sec:exchnameen" id="ixv-282">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">((&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging Growth Company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-05-20_to_2025-05-20" format="ixt-sec:boolballotbox" id="ixv-283">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;7.01.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;20, 2025, Teva Pharmaceutical Industries Limited (the &#8220;Company&#8221;) issued a press release announcing the pricing of the Securities (as defined below). A copy of the related press release issued by the Company is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and incorporated herein in its entirety. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 and Exhibit 99.1 hereto is being furnished to the Securities and Exchange Commission (the &#8220;Commission&#8221;) and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act or the Exchange Act, except as set forth by specific reference in such filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;20, 2025, Teva Pharmaceutical Finance Netherlands II B.V. (&#8220;Teva Finance II&#8221;), Teva Pharmaceutical Finance Netherlands III B.V. (&#8220;Teva Finance III&#8221;), Teva Pharmaceutical Finance Netherlands IV B.V. (&#8220;Teva Finance IV&#8221; and together with Teva Finance II and Teva Finance III, the &#8220;Issuers&#8221;) and, the Company, as guarantor, entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with BNP PARIBAS, BNP Paribas Securities Corp., BofA Securities Europe SA, BofA Securities, Inc. HSBC Continental Europe, HSBC Bank plc, Intesa Sanpaolo S.p.A. and J.P.&#160;Morgan SE, as representatives for the underwriters named in Schedule 1 annexed thereto (the &#8220;Underwriters&#8221;), providing for the offer and sale by Teva Finance II of &#8364;1,000,000,000 aggregate principal amount of 4.125% Senior Notes due 2031 (the &#8220;Euro Notes&#8221;), providing for the offer and sale by Teva Finance III of $500,000,000 aggregate principal amount of 6.000% Senior Notes due 2032 (the &#8220;2032 USD Notes&#8221;) and providing for the offer and sale by Teva Finance IV of $700,000,000 aggregate principal amount of 5.750% Senior Notes due 2030 (the &#8220;2030 USD Notes&#8221; and, together with the 2032 USD Notes and the Euro Notes, the &#8220;Securities&#8221;). The sale of the Securities is expected to close on May&#160;28, 2025. The offering of the Euro Notes was priced at 99.349% of the &#8364;1,000,000,000 principal amount of the Euro Notes to be issued. The offering of the 2032 USD Notes was priced at 99.256% of the $500,000,000 principal amount of the 2032 USD Notes to be issued. The offering of the 2030 USD Notes was priced at 99.418% of the $700,000,000 principal amount of the 2030 USD Notes to be issued. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offering of the Securities was registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and is being made pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR</span> (File <span style="white-space:nowrap">No.&#160;333-284770)</span> and the prospectus included therein (the &#8220;Registration Statement&#8221;), filed by the Company with the Commission on February&#160;7, 2025, and the prospectus supplement relating thereto, dated May&#160;19, 2025, and filed with the Commission on May&#160;19, 2025 pursuant to Rule 424(b)(5) promulgated under the Securities Act. The Underwriting Agreement contains customary representations, warranties and covenants of the Company and the Issuers. It also provides for customary indemnification by each of the Company, the Issuers and the Underwriters against certain liabilities and customary contribution provisions in respect of those liabilities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the material terms of the Underwriting Agreement is qualified in its entirety by reference to the copy thereof which is filed herewith as Exhibit 1.1 and incorporated herein by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Exhibit</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d929611dex11.htm">Underwriting Agreement, dated as of May&#160;20, 2025, among the Issuers, the Company, BNP PARIBAS, BNP Paribas Securities Corp., BofA Securities Europe SA, BofA Securities, Inc., HSBC Bank plc, HSBC Continental Europe, Intesa Sanpaolo S.p.A. and J.P. Morgan SE as representatives for the underwriters named in Schedule 1 annexed thereto. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d929611dex991.htm">Press Release dated May&#160;20, 2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The cover page of this Current Report on Form <span style="white-space:nowrap">8-K,</span> formatted in Inline XBRL.</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: May&#160;22, 2025 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0">


<tr>

<td style="width:13%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:86%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eli Kalif</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Eli Kalif</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, Chief Financial Officer</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d929611dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#128;1,000,000,000 4.125% Senior Notes due 2031 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$500,000,000 6.000% Senior Notes due 2032 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS IV B.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$700,000,000 5.750% Senior Notes due 2030 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Payment of principal and interest unconditionally guaranteed by </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL INDUSTRIES LIMITED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>UNDERWRITING AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">May&nbsp;20, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BNP PARIBAS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities Europe SA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HSBC Continental Europe </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intesa Sanpaolo S.p.A. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan SE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as Euro Representatives (as defined herein) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BNP PARIBAS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16, boulevard des Italiens </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">75009 Paris </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">France </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities Europe SA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">51 rue La Bo&eacute;tie </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">75008 Paris </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">France </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HSBC Continental Europe </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">38, avenue Kl&eacute;ber </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">75116 Paris </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">France </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intesa Sanpaolo S.p.A., Divisione IMI </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Corporate&nbsp;&amp;
Investment Banking </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Via Manzoni </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4 &#150; 20121, Milan </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Italy </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan SE </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Taunustor 1 (TaunusTurm) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">60310 Frankfurt am Main </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Germany </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To: the other Euro Underwriters (as defined herein)
listed in Part A of Schedule I hereto </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BNP
Paribas Securities Corp. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HSBC Bank
plc </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intesa Sanpaolo S.p.A. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan SE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as 2032 Dollar Representatives and 2030 Dollar Representatives (each, as defined herein) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BNP Paribas Securities Corp. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">787 Seventh Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States of America </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Bryant Park </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10036 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States of America </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HSBC Bank plc </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8 Canada Square </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">London E14 5HQ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United Kingdom </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intesa Sanpaolo S.p.A., Divisione IMI </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Corporate&nbsp;&amp; Investment Banking </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Via Manzoni </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4 &#150; 20121, Milan </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Italy </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan SE </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Taunustor 1 (TaunusTurm) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">60310 Frankfurt am Main </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Germany </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To: the other 2032 Dollar Underwriters (as defined herein) listed in Part B of Schedule I hereto and the other 2030 Dollar Underwriters (as defined herein)
listed in Part C of Schedule I hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands II B.V. (the &#147;<B><U>Euro Notes Issuer</U></B>&#148;), a private company with limited liability
(<I>besloten vennootschap met beperkte aansprakelijkheid</I>) organized under the laws of the Netherlands and an indirect wholly-owned subsidiary of Teva Pharmaceutical Industries Limited, a company organized under the laws of Israel (the
&#147;<B><U>Guarantor</U></B>&#148;), proposes, subject to the terms and conditions stated herein, to issue and sell &#128;1,000,000,000 in aggregate principal amount of its 4.125% Senior Notes due 2031 (the &#147;<B><U>2031 Euro
Notes</U></B>&#148;), which Euro Notes are to be guaranteed by the Guarantor (the &#147;<B><U>Euro Guarantees</U></B>&#148; and, together with the Euro Notes, the &#147;<B><U>Euro Securities</U></B>&#148;), to the underwriters named in Part A of
Schedule I hereto (individually, each a &#147;<B><U>Euro Underwriter</U></B>&#148; and, collectively, the &#147;<B><U>Euro Underwriters</U></B>&#148;), for whom BNP PARIBAS, BofA Securities Europe SA, HSBC Continental Europe, Intesa Sanpaolo S.p.A.
and J.P. Morgan SE are acting as representatives (the &#147;<B><U>Euro Representatives</U></B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands III B.V. (the &#147;<B><U>2032 Dollar Notes
Issuer</U></B>&#148;), a private company with limited liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>) organized under the laws of the Netherlands and an indirect wholly-owned subsidiary of the Guarantor, proposes, subject to
the terms and conditions stated herein, to issue and sell $500,000,000 in aggregate principal amount of its 6.000% Senior Notes due 2032 (the &#147;<B><U>2032 Dollar Notes</U></B>&#148;), which are to be guaranteed by the Guarantor (the
&#147;<B><U>2032 Dollar Guarantees</U></B>&#148; and, together with the 2032 Dollar Notes, the &#147;<B><U>2032 Dollar Securities</U></B>&#148;), to the underwriters named in Part B of Schedule I hereto (individually, each a &#147;<B><U>2032 Dollar
Underwriter</U></B>&#148; and collectively, the &#147;<B><U>2032 Dollar Underwriters</U></B>&#148;), for whom BNP Paribas Securities Corp., BofA Securities, Inc., HSBC Bank plc, Intesa Sanpaolo S.p.A. and J.P. Morgan SE are acting as representatives
(the &#147;<B><U>2032 Dollar Representatives</U></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands IV B.V. (the &#147;<B><U>2030 Dollar
Notes Issuer</U></B>&#148; and, together with the 2032 Dollar Notes Issuer, the &#147;<B><U>Dollar Notes Issuers</U></B>&#148; and, together with the Euro Notes Issuer, the &#147;<B><U>Issuers</U></B>&#148;), a private company with limited liability
(<I>besloten vennootschap met beperkte aansprakelijkheid</I>) organized under the laws of the Netherlands and an indirect wholly-owned subsidiary of the Guarantor, proposes, subject to the terms and conditions stated herein, to issue and sell
$700,000,000 in aggregate principal amount of its 5.750% Senior Notes due 2030 (the &#147;<B><U>2030 Dollar Notes</U></B>&#148;) and, together with the 2032 Dollar Notes, the &#147;<B><U>Dollar Notes</U></B>&#148; and, together with the Euro Notes,
the &#147;<B><U>Notes</U></B>&#148;), which 2030 Dollar Notes are to be guaranteed by the Guarantor (the &#147;<B><U>2030</U></B><U> </U><B><U>Dollar Guarantees</U></B>&#148; and, together with the 2030 Dollar Notes, the &#147;<B><U>2030 Dollar
Securities</U></B>&#148; and, the 2030 Dollar Guarantees together with the 2032 Dollar Guarantees, the &#147;<B><U>Dollar Guarantees</U></B>&#148; and, together with the Euro Guarantees, the &#147;<B><U>Guarantees</U></B>&#148; and, the 2030 Dollar
Securities together with the 2032 Dollar Securities, the &#147;<B><U>Dollar Securities</U></B>&#148; and, together with the Euro Securities, the &#147;<B><U>Securities</U></B>&#148;), to the underwriters named in Part C of Schedule I hereto
(individually, each a &#147;<B><U>2030 Dollar Underwriter</U></B>&#148; and collectively, the &#147;<B><U>2030 Dollar Underwriters</U></B>&#148; and, together with the 2032 Dollar Underwriters, the &#147;<B>Dollar Underwriters</B>&#148; and,
together with the Euro Underwriters, the &#147;<B><U>Underwriters</U></B>&#148; and each individually an &#147;<B><U>Underwriter</U></B>&#148;), for whom BNP Paribas Securities Corp., BofA Securities, Inc., HSBC Bank plc, Intesa Sanpaolo S.p.A. and
J.P. Morgan SE are acting as representatives (the &#147;<B><U>2030 Dollar</U></B><U> </U><B><U>Representatives</U></B>&#148;) and, together with the 2032 Dollar Representatives, the &#147;<B><U>Dollar Representatives</U></B>&#148; and, together with
the Euro Representatives, the &#147;<B><U>Representatives</U></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Euro Securities will be issued pursuant to an indenture,
dated as of March 14, 2018 (such indenture, the &#147;<B><U>Existing Euro Notes Indenture</U></B>&#148;), to be supplemented by a fifth supplemental indenture (the &#147;<B><U>Supplemental Euro Notes Indenture</U></B>&#148;) to be dated as of the
Delivery Date (as defined in Section&nbsp;2(a)), among the Euro Notes Issuer, the Guarantor, The Bank of New York Mellon, as trustee (the &#147;<B><U>Trustee</U></B>&#148;) and The Bank of New York Mellon, London Branch, as principal paying agent.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The 2032 Dollar Securities will be issued pursuant to an indenture, dated as of March&nbsp;14, 2018 (such indenture, the
&#147;<B><U>Existing 2032 Dollar Notes Indenture</U></B>&#148; and, together with the Existing Euro Notes Indenture, the &#147;<B><U>Existing Indentures</U></B>&#148;), to be supplemented by a fifth supplemental indenture (the
&#147;<B><U>Supplemental 2032 Dollar Notes Indenture</U></B>&#148;) to be dated as of the Delivery Date, among the 2032 Dollar Notes Issuer, the Guarantor and the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The 2030 Dollar Securities will be issued pursuant to an indenture, to be dated as of the Delivery Date (such indenture, the &#147;<B><U>2030
Dollar </U></B><B><U>Indenture</U></B>&#148;), to be supplemented by a supplemental indenture to be dated as of the Delivery Date (the &#147;<B><U>Supplemental 2030 Dollar Notes Indenture</U></B>&#148; and, together with the Supplemental Euro Notes
Indenture and the Supplemental 2032 Dollar Notes Indenture, the &#147;<B><U>Supplemental Indentures</U></B>&#148; and, the Supplemental Indentures together with the Existing Indentures and the 2030 Dollar Indenture, the
&#147;<B><U>Indentures</U></B>&#148; and each individually an &#147;<B><U>Indenture</U></B>&#148;), among the 2030 Dollar Notes Issuer, the Guarantor, and the Trustee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Underwriters have advised the Issuers and the Guarantor that they will offer and sell
the Securities purchased from the Issuers and the Guarantor hereunder in accordance with Section&nbsp;2 of this Agreement as soon as they deem advisable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This Agreement, the Indentures and the Notes are referred to herein collectively as the &#147;<B><U>Operative Documents</U></B>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any reference herein to the Registration Statement, the Prospectus and the Preliminary Prospectus shall be deemed to refer to and include the
Incorporated Documents as of the Effective Time of the Registration Statement or the issue date of such Prospectus or Preliminary Prospectus, respectively, and any reference herein to the terms &#147;amend,&#148; &#147;amendment&#148; or
&#147;supplement&#148; with respect to the Registration Statement, the Prospectus and the Preliminary Prospectus shall be deemed to refer to and include the filing of any document under the Securities Exchange Act of 1934, as amended (the
&#147;<B><U>Exchange Act</U></B>&#148;), after the Effective Time of the Registration Statement or the issue date of the Prospectus or Preliminary Prospectus, respectively, deemed to be incorporated therein by reference. Certain capitalized terms
used herein are defined in Section&nbsp;22. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This is to confirm the agreement between the Issuers, the Guarantor and the Underwriters
concerning the issue, offer and sale of the Securities. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Representations, Warranties and Agreements of the Issuers and the Guarantor.</I></B>
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Each of the Issuers (except for the representation in Section&nbsp;1(mm), which is given by the Euro Notes Issuer only)
and the Guarantor, jointly and severally, represent, warrant to and agree with, the Underwriters that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The
Registration Statement, setting forth information with respect to the Issuers, the Guarantor and the Securities is an automatic shelf registration statement as defined in Rule 405 of the rules and regulations of the Securities and Exchange
Commission (the &#147;<B><U>Commission</U></B>&#148;) under the Securities Act (the &#147;<B><U>Rules and Regulations</U></B>&#148;). The Registration Statement, including the Base Prospectus, has (i)&nbsp;been prepared by the Issuers and the
Guarantor in conformity in all material respects with the requirements of the Securities Act of 1933, as amended (the &#147;<B><U>Securities Act</U></B>&#148;), (ii) been filed with the Commission under the Securities Act and (iii)&nbsp;become
effective upon filing under the Securities Act. The Issuers and the Guarantor have included in such Registration Statement, as amended at the Effective Time, all information required by the Securities Act and the rules thereunder to be included in
such Registration Statement and the Base Prospectus. The Issuers may have filed with the Commission a Preliminary Prospectus pursuant to Rule 424(b) of the Rules and Regulations, which has previously been furnished to the Underwriters. The Issuers
and the Guarantor will file with the Commission the Prospectus in accordance with Rule 424(b) of the Rules and Regulations. As filed, such Prospectus will contain all information required by the Securities Act and the Rules and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
Regulations, and, except to the extent the Representatives will agree in writing to a modification, will be in all substantial respects in the form furnished to the Underwriters prior to the
Execution Time, or, to the extent not completed at the Execution Time, shall contain only such additional information and other changes as the Issuers and Guarantor have advised the Underwriters, prior to the Execution Time, will be included or made
therein or such changes as are made after consulting with the Underwriters or their counsel. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The conditions for use
of Form <FONT STYLE="white-space:nowrap">S-3,</FONT> as set forth in the general instructions thereto, have been satisfied or waived. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Registration Statement conforms, and the Prospectus and any further amendments or supplements to the Registration
Statement or the Prospectus will, when they are filed with the Commission, conform in all material respects to the requirements of the Securities Act and the Trust Indenture Act of 1939, as amended (the &#147;<B><U>Trust Indenture
Act</U></B>&#148;). The Registration Statement and any amendment thereto did not, as of the Effective Time and at the Execution Time, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or
necessary in order to make the statements therein, not misleading. The Preliminary Prospectus as of its date did not, and the Prospectus, as of the date thereof and on the Delivery Date does not and will not contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, it being understood that none of the Issuers or the
Guarantor makes any representation or warranty as to (i)&nbsp;information contained in or omitted from the Registration Statement or the Prospectus in reliance upon and in conformity with written information furnished to the Issuers and the
Guarantor by the Representatives, on behalf of the Underwriters, specifically for inclusion therein as provided in Section&nbsp;7(e) and (ii)&nbsp;that part of the Registration Statement that constitutes the Statement of Eligibility and
Qualification (Form <FONT STYLE="white-space:nowrap">T-1)</FONT> of the Trustee under the Trust Indenture Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The
Incorporated Documents as amended or supplemented at the date hereof, when they were filed with the Commission, conformed in all material respects to the requirements of the Securities Act and the Exchange Act, as applicable. None of the
Incorporated Documents as amended or supplemented at the date hereof, when such documents were filed with the Commission, contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Any further documents so filed and incorporated by reference in the Prospectus, when such documents are filed with the
Commission, will conform in all material respects to the requirements of the Exchange Act and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) (i) The Disclosure Package, when taken together as a whole, and
(ii)&nbsp;each electronic road show, when taken together as a whole with the Disclosure Package, as of the Execution Time, do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to information contained in or omitted from the Disclosure Package or in any electronic road show in reliance
upon and in conformity with written information furnished to the Issuers and the Guarantor by the Representatives, on behalf of the Underwriters, specifically for inclusion therein as provided in Section&nbsp;7(e). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) (i) At the time of filing the Registration Statement, (ii)&nbsp;at the time of the most recent amendment thereto, if any,
for the purposes of complying with Section&nbsp;10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Sections 13 or 15(d) of the Exchange Act or form of prospectus), (iii) at
the time the Issuers and the Guarantor or any person acting on their behalf (within the meaning, for this clause only, of Rule 163(c) of the Rules and Regulations) made any offer relating to the Securities in reliance on the exemption in Rule 163 of
the Rules and Regulations, and (iv)&nbsp;at the Execution Time (with such date being used as the determination date for purposes of this clause (iv)), the Guarantor was or is (as the case may be) a &#147;well-known seasoned issuer&#148; as defined
in Rule 405 of the Rules and Regulations. The Issuers and the Guarantor agree to pay the fees required by the Commission relating to the Securities within the time required by Rule 456(b)(1) of the Rules and Regulations without regard to the proviso
therein and otherwise in accordance with Rules 456(b) and 457(r) of the Rules and Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) (i) At the earliest
time after the filing of the Registration Statement that the Issuers or the Guarantor or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the Rules and Regulations) of the Securities and (ii)&nbsp;as of
the Execution Time (with such date being used as the determination date for purposes of this clause (ii)), the Issuers and the Guarantor were not and are not Ineligible Issuers (as defined in Rule 405 of the Rules and Regulations), without taking
account of any determination by the Commission pursuant to Rule 405 of the Rules and Regulations that it is not necessary that either the Issuers or the Guarantor be considered an Ineligible Issuer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Each Issuer Free Writing Prospectus and the final term sheet prepared and filed pursuant to Section&nbsp;3(c) hereto do
not include any information that conflicts with the information contained in the Registration Statement, including the Incorporated Documents and the Preliminary Prospectus and the Prospectus deemed to be a part thereof that has not been superseded
or modified. The preceding sentence does not apply to information contained in or omitted from the Issuer Free Writing Prospectus in reliance upon and in conformity with written information furnished to the Issuers and the Guarantor by the
Representatives, on behalf of the Underwriters, specifically for inclusion therein as provided in Section&nbsp;7(e). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Each of the Issuers and the Guarantor have not engaged in any form of
solicitation, advertising or other action constituting an offer or a sale under the Israeli Securities Law 5728-1968, as amended (the &#147;<B><U>Israeli Securities Law</U></B>&#148;), and the regulations promulgated thereunder in connection with
the offer and sale of the Securities contemplated hereby, other than offering Securities solely to qualified investors of the type listed on the First Addendum to the Israeli Securities Law, and, assuming the Underwriters&#146; compliance with
Section&nbsp;6(h) hereof, are not required to publish a prospectus in Israel with respect to the offer and sale of the Securities contemplated hereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Each of the Guarantor and each &#147;significant subsidiary&#148; of the Guarantor (as such term is defined in Rule <FONT
STYLE="white-space:nowrap">1-02(w)</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X)</FONT> (each, a &#147;<B><U>Significant Subsidiary</U></B>&#148; and, collectively, the &#147;<B><U>Significant Subsidiaries</U></B>&#148;) has been duly
organized and is validly existing in good standing (in all jurisdictions in which such concept is relevant) under the laws of the jurisdiction in which it is chartered or organized, is duly qualified to do business and is in good standing as a
foreign corporation in each jurisdiction in which its ownership or lease of property or the conduct of its business requires such qualification (except for where the failure to be so qualified would not have a material adverse effect on the
business, properties, financial condition, results of operations or prospects of the Guarantor and its subsidiaries, taken as a whole, and except as set forth in or contemplated in each of the Disclosure Package and the Prospectus (exclusive of any
amendment or supplement thereto) (a &#147;<B><U>Material Adverse Effect</U></B>&#148;)), and has all corporate power and authority necessary to own or hold its properties and to conduct its business as described in each of the Disclosure Package and
the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Each of the Issuers has been duly organized and is validly existing as a private company with limited
liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>) under the laws of the Netherlands, is qualified to do business and is in good standing as a foreign corporation in each jurisdiction in which its ownership or lease of property
or the conduct of its businesses requires such qualification (except for where the failure to be so qualified would not have a Material Adverse Effect), and has all corporate power and authority necessary to own or hold its properties and to conduct
its businesses as described in each of the Disclosure Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) All of the outstanding shares of
capital stock of each Significant Subsidiary of the Guarantor have been duly and validly authorized and issued and are fully paid and nonassessable, and, except as otherwise set forth in each of the Disclosure Package and the Prospectus, all
outstanding shares of capital stock of such subsidiaries are owned by the Guarantor either directly or through wholly-owned subsidiaries free and clear of any perfected security interest or any other security interests, claims, liens or
encumbrances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) All of the outstanding shares of capital stock of each of the Issuers
have been duly authorized and validly issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and were not issued in violation of any preemptive or similar rights granted pursuant to the organizational documents of each of
the Issuers or any statutory provisions of Dutch law, and all outstanding shares of each of the Issuers are owned by the Guarantor either directly or through wholly-owned subsidiaries free and clear of any perfected security interest or any other
security interests, claims, liens or encumbrances. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) The Guarantor has an authorized capitalization as set forth in
each of the Disclosure Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) The statements contained in each of the Preliminary Prospectus and
the Prospectus under the caption &#147;<I>Description of the Euro Notes and the Guarantees</I>&#148; and &#147;<I>Description of the USD Notes and the Guarantees,</I>&#148; as supplemented by the final term sheet prepared and filed pursuant to
Section&nbsp;3(c) hereof, insofar as they purport to summarize the provisions of the Indentures and the Securities, are accurate and complete in all material respects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) Neither the execution, delivery and performance of this Agreement and the other Operative Documents by the applicable
Issuer and the Guarantor, nor the issuance of the Securities under this Agreement will (x)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of
trust, loan agreement or other agreement or instrument to which such Issuer or the Guarantor is a party or by which such Issuer or the Guarantor is bound or to which any of the properties or assets of such Issuer or the Guarantor is subject, except
for any conflict, breach or violation that would not have, individually or in the aggregate, a Material Adverse Effect, (y)&nbsp;result in any violation of the provisions of the memorandum of association or the articles of association of the
Guarantor or the organizational documents of such Issuer or (z)&nbsp;result in any violation in any material respect of any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the applicable
Issuer or the Guarantor or any of their respective properties or assets; and except (i)&nbsp;such as have been or will be obtained under the Securities Act, the Trust Indenture Act and the rules and regulations promulgated thereunder, (ii)&nbsp;as
may be required by the securities or &#147;blue sky&#148; laws of any state of the United States, (iii)&nbsp;as may be required under the applicable laws of the Netherlands, (iv)&nbsp;for the filing or furnishing of public announcements in
connection with the issue and offer of the Securities with the Commission, the New York Stock Exchange, the Israel Securities Authority, the Tel Aviv Stock Exchange and the Israeli Companies Registrar that may be required to be made on or after the
date of this Agreement and the Closing Date, as applicable, and (v)&nbsp;with respect to the Euro Notes only, as may be required under the rules and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
regulations of the Euronext Dublin with respect to the listing thereon of the Euro Notes, no consent, approval, authorization or order of, or filing or registration with, any such court or
governmental agency or body is required for the execution, delivery and performance of the Operative Documents by each of the Issuers and the Guarantor, and the consummation of the offer and sale of the Securities contemplated hereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) Each of the Issuers and the Guarantor has all necessary corporate right, power and authority to execute and deliver this
Agreement and perform its obligations hereunder; and this Agreement, and the offer and sale of the Securities contemplated hereby, have been duly authorized, and this Agreement has been duly executed and delivered by each of the Issuers and the
Guarantor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) Each of the Issuers and the Guarantor has all necessary corporate right, power and authority to execute
and deliver each of the Supplemental Indentures to which it is party and perform its obligations thereunder; each of the Supplemental Indentures has been duly authorized by the Issuer party thereto and the Guarantor, and on the Delivery Date, each
of the Supplemental Indentures will be qualified under the Trust Indenture Act and will have been duly executed and delivered by the Issuer party thereto and the Guarantor and, assuming due authorization, execution and delivery of each of the
Supplemental Indentures by the Trustee and (in the case of the Supplemental Euro Notes Indenture) the principal paying agent party thereto, will constitute a legally valid and binding agreement of each of the Issuers party thereto and the Guarantor,
enforceable against each of the Issuers party thereto and the Guarantor in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar
laws relating to or affecting creditors&#146; rights generally, subject to general principles of equity and to limitations on availability of equitable relief, including specific performance (whether considered in a proceeding in equity or at law)
and an implied covenant of good faith and fair dealing (collectively, the &#147;<B><U>Enforceability Exceptions</U></B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) Each of the 2030 Dollar Notes Issuer and the Guarantor has all necessary corporate right, power and authority to execute
and deliver the 2030 Dollar Indenture and perform its obligations thereunder; the 2030 Dollar Indenture has been duly authorized by the 2030 Dollar Notes Issuer and the Guarantor, and on the Delivery Date, the 2030 Dollar Indenture will be qualified
under the Trust Indenture Act and will have been duly executed and delivered by the 2030 Dollar Notes Issuer and the Guarantor and, assuming due authorization, execution and delivery of the 2030 Dollar Indenture by the Trustee, will constitute a
legally valid and binding agreement of the 2030 Dollar Notes Issuer and the Guarantor, enforceable against the 2030 Dollar Notes Issuer and the Guarantor in accordance with its terms, except as the enforceability thereof may be limited by the
Enforceability Exceptions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) Each of the Existing Indentures has been duly authorized, executed and
delivered by the Issuer party thereto and the Guarantor, and, assuming due authorization, execution and delivery of each of the Existing Indentures by the Trustee and (in the case of the Existing Euro Notes Indenture) the principal paying agent
party thereto, constitutes a legally valid and binding agreement of each of the Issuers party thereto and the Guarantor, enforceable against each of the Issuers party thereto and the Guarantor in accordance with its terms, except as the
enforceability thereof may be limited by the Enforceability Exceptions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) Each of the Issuers and the Guarantor has all
necessary corporate right, power and authority to execute, issue and deliver the Notes and Guarantees, respectively, and perform its obligations thereunder; the Notes have been duly authorized by each of the applicable Issuers and the Guarantees
have been duly authorized by the Guarantor; when the Notes are executed, authenticated and issued in accordance with the terms of the applicable Indenture and delivered to and paid for by the Underwriters pursuant to this Agreement on the Delivery
Date (assuming due authentication of the Notes by the Trustee), such Notes will constitute legally valid and binding obligations of each of the applicable Issuers, entitled to the benefits of the applicable Indenture and enforceable against each of
the applicable Issuers in accordance with their terms, except as the enforceability thereof may be limited by the Enforceability Exceptions; when the Guarantees are executed and issued in accordance with the terms of the applicable Indenture and the
Notes on which they are endorsed have been executed in accordance with the applicable Indenture and delivered to and paid for by the Underwriters pursuant to this Agreement on the Delivery Date, such Guarantees will constitute legally valid and
binding obligations of the Guarantor, and enforceable against the Guarantor in accordance with their terms, except as the enforceability thereof may be limited by the Enforceability Exceptions, and entitled to the benefit of the applicable
Indenture. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) Except as described in each of the Disclosure Package and the Prospectus, there are no contracts,
agreements or understandings between each of the Issuers or the Guarantor and any person granting such person the right (other than rights which have been waived or satisfied) to require the Issuers or the Guarantor to file a registration statement
under the Securities Act with respect to any securities of the Issuers or the Guarantor owned or to be owned by such person or to require the Issuers or the Guarantor to include such securities in any securities being registered pursuant to any
registration statement filed by the Issuers or the Guarantor under the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) Except as would not have a
Material Adverse Effect, (x)&nbsp;the Guarantor, since the date of the latest audited financial statements incorporated by reference in the Disclosure Package, and (y)&nbsp;each of the Issuers, at any time since its respective formation, has not
sustained any loss or interference with its respective business from fire, explosion, flood or other calamity, whether or not covered by insurance, or, except as described in each of the Disclosure Package
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
and the Prospectus, from any labor dispute or court or governmental action, order or decree; and (i)&nbsp;with respect to each of the Issuers, since the respective date on which it became a
wholly-owned subsidiary of the Guarantor, and (ii)&nbsp;with respect to the Guarantor, since the date of the most recent audited financial statements incorporated by reference in the Disclosure Package, except for the transactions contemplated
hereby or as described in each of the Disclosure Package and the Prospectus, there has not been any change in such entity&#146;s respective capital stock or long-term debt of each of the Issuers or the Guarantor, or any change or any development
including a prospective change that would have a Material Adverse Effect, except for any grants under the employee stock plans of the Guarantor or its subsidiaries (the &#147;<B><U>Authorized Grants</U></B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) The consolidated financial statements of the Guarantor (including the related notes and supporting schedules) incorporated
by reference in the Disclosure Package present fairly, in all material respects, the financial condition and results of operations of the Guarantor and its consolidated subsidiaries at the dates and for the periods indicated, comply as to form in
all material respects with the applicable accounting requirements of the Securities Act and the Rules and Regulations and have been prepared in conformity with generally accepted accounting principles in the United States applied on a consistent
basis throughout the periods involved, subject to, only in the case of the unaudited financial statements, ordinary <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) Kesselman&nbsp;&amp; Kesselman, who audited the annual financial statements of the Guarantor, incorporated by reference in
each of the Disclosure Package and the Prospectus, and whose report is incorporated by reference therein, is the independent registered accounting firm with respect to the Guarantor within the meaning of the Securities Act and the Rules and
Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) Except as would not have a Material Adverse Effect and except as disclosed in each of the Disclosure
Package and the Prospectus, the Guarantor and its subsidiaries own or possess, or hold valid licenses in respect of, all patents, patent rights, licenses, inventions, copyrights, <FONT STYLE="white-space:nowrap">know-how,</FONT> trade secrets,
trademarks, service marks and trade names necessary for the conduct of their respective businesses in the manner described in each of the Disclosure Package and the Prospectus, and, except as described in each of the Disclosure Package and the
Prospectus, the Guarantor has not received any notice of, and has no knowledge of, any infringement of or conflict with asserted rights of others with respect to any of the foregoing which, singly or in the aggregate, would be reasonably likely to
have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) Each of the Issuers and the Guarantor possesses all certificates,
authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct its business as now conducted and as described in each of the Disclosure Package and the Prospectus, except for such
certificate, authorizations and permits the failure of which to possess, singly or in the aggregate, would not have a Material Adverse Effect, and neither the Issuers nor the Guarantor have received any notice of proceedings relating to the
revocation or modification of any such certificate, authorization or permit, which singly or in the aggregate, would be reasonably likely to have a Material Adverse Effect, except as described in each of the Disclosure Package and the Prospectus.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb) Except as disclosed in each of the Disclosure Package and the Prospectus, there are no legal or governmental
proceedings pending to which either of the Issuers or the Guarantor or any subsidiary of the Guarantor is a party or of which any property or asset of the Issuers or the Guarantor or any subsidiary of the Guarantor is the subject which, singly or in
the aggregate, would be reasonably likely to have a Material Adverse Effect; and to the knowledge of each of the Issuers and the Guarantor, no such proceedings are threatened or contemplated by governmental authorities or, except as set forth or
contemplated in each of the Disclosure Package and the Prospectus, threatened by others. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc) Each of the Issuers and the
Guarantor is not (i)&nbsp;in violation of its organizational documents, (ii)&nbsp;in default and no event has occurred which, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term,
covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which it is a party or by which it is bound or to which any of its properties or assets is subject or (iii)&nbsp;in
violation of any law, ordinance, governmental rule, regulation or court decree to which it or its properties or assets may be subject or has failed to obtain any license, permit, certificate, franchise or other governmental authorization or permit
necessary to the ownership of its properties or to the conduct of its business, except to the extent that any such default, event or violation described in the foregoing clauses (ii)&nbsp;and (iii) would not have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) The Guarantor is subject to and in compliance in all material respects with the reporting requirements of Sections 13 and
15(d) of the Exchange Act and the rules and regulations promulgated under the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee) The Guarantor and its
subsidiaries (i)&nbsp;are in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants
or contaminants (&#147;<B><U>Environmental Laws</U></B>&#148;), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii)&nbsp;are in compliance
with all terms and conditions of any such permit, license or approval, except in each case of clauses (i), (ii) and (iii)&nbsp;where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or
failure to comply with the terms and conditions of such permits, licenses or approvals would not, singly or in the aggregate, have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ff) Each of the Guarantor and its subsidiaries, in its reasonable
judgment, has concluded that there are no costs or liabilities associated with its respective compliance with Environmental Laws (including, without limitation, any capital or operating expenditures required for
<FONT STYLE="white-space:nowrap">clean-up,</FONT> closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties) which
would, singly or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(gg) There are no stamp or other issuance or transfer
taxes or duties or other similar fees or charges required to be paid, under Israeli or U.S. federal law or the laws of any U.S. state, by or on behalf of the Underwriters in connection with (A)&nbsp;the issuance, sale and delivery of the Securities
to be sold by the Issuers in the manner contemplated by this Agreement, (B)&nbsp;the sale and delivery by the Underwriters of the Securities as contemplated herein or (C)&nbsp;the execution and delivery of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hh) Each of the Issuers and the Guarantor has filed all foreign, national, federal, state and local tax returns that are
required to be filed or has requested extensions thereof (except in any case in which the failure so to file would not have a Material Adverse Effect) and has paid (or withheld) all taxes required to be paid (or withheld) by it and any other
assessment, fine or penalty levied against it, to the extent that any of the foregoing is due and payable, except for any such assessment, fine or penalty that is currently being contested in good faith or as would not have a Material Adverse
Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) No subsidiary of the Guarantor (other than each of the Issuers) is currently prohibited, directly or
indirectly, from paying any dividends to the Guarantor, from making any other distribution on such subsidiary&#146;s capital stock, from repaying to the Guarantor any loans or advances to such subsidiary from the Guarantor or from transferring any
of such subsidiary&#146;s property or assets to the Guarantor or any other subsidiary of the Guarantor, except as described in or contemplated by each of the Disclosure Package and the Prospectus or except as would not have a Material Adverse
Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(jj) Each of the Issuers and the Guarantor, as of the date hereof and the Closing Date, maintains a system of
internal accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific
authorization; and (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(kk) Neither of the Issuers nor the Guarantor is, nor, after giving effect
to the offering and sale of the Securities and the application of the proceeds therefrom as described in the Disclosure Package and the Prospectus, as supplemented by the by the final term sheet prepared and filed pursuant to Section&nbsp;3(c)
hereof, will be an &#147;investment company&#148; or an entity &#147;controlled&#148; by an &#147;investment company&#148; within the meaning of such term under the Investment Company Act of 1940, as amended (the &#147;<B><U>Investment Company
Act</U></B>&#148;), and the rules and regulations of the Commission thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ll) Except as disclosed in the
Disclosure Package or the Prospectus, payments of interest in respect of the Securities held by <FONT STYLE="white-space:nowrap">non-Israeli</FONT> residents are not subject to withholding or deduction for or on account of any taxes, duties or other
charges of whatever nature imposed by Israel or any authority thereof or therein having the power to tax. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(mm)
Application has been made to admit the Euro Notes to the Official List of Euronext Dublin and trading on the Global Exchange Market and, in connection therewith, the Euro Notes Issuer has caused to be prepared and submitted to Euronext Dublin a
listing application with respect to the Euro Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(nn) Neither the Guarantor nor any of its subsidiaries nor any of
their respective directors, officers or, to the knowledge of the Guarantor, any agents, employees or affiliates acting on behalf of the Guarantor or any of its subsidiaries is a person or entity with whom dealings are restricted or prohibited
pursuant to any sanctions administered by the United States (including the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S. Department of State or the U.S. Department of Commerce) or any sanctions imposed by the
United Nations Security Council, the European Union, His Majesty&#146;s Treasury of the United Kingdom or other relevant sanctions authority, excluding the Arab League (collectively, the &#147;<B><U>Sanctions</U></B>&#148; and each such person or
entity, a &#147;<B><U>Sanctioned Person</U></B>&#148;), nor is the Guarantor or any of its subsidiaries operating, resident or organized under the laws of a country or territory that is the subject of Sanctions that comprehensively prohibit dealings
with that country or territory (which currently comprise Cuba, Iran, Syria, North Korea and the <FONT STYLE="white-space:nowrap">non-government</FONT> controlled parts of Ukraine (including the Crimea Region of Ukraine, the <FONT
STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#146;s Republic, the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#146;s Republic, Zaporizhzhia and Kherson) (each, a &#147;<B><U>Sanctioned Country</U></B>&#148;); and
neither of the Issuers nor the Guarantor will directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person
or entity, for the purpose of financing the activities of or business with: (i)&nbsp;any Sanctioned Person except insofar as the relevant conduct is licensed (or is equivalent to that described in published licenses or authorizations); (ii) any
Sanctioned Country except insofar as the relevant conduct is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
licensed (or is equivalent to that described in published licenses or authorizations); or (iii)&nbsp;any other activities or services that would give rise to a violation of Sanctions by the
Underwriters, the Issuers or the Guarantor. Further, it is acknowledged and agreed that this representation given pursuant to this Section&nbsp;1(nn) is sought and given if and to the extent that to do so would not result in any violation or breach
of any provision of (and in no case may be construed as requiring any party to this Agreement to act in violation or breach of)&nbsp;(i) Council Regulation (EC) No 2271/96 of 22&nbsp;November 1996, as amended and in force (or any law or regulation
implementing such Regulation in any member state of the European Union), or (ii)&nbsp;the United Kingdom&#146;s blocking statute (including The Protecting against the Effects of the Extraterritorial Application of Third Country Legislation
(Amendment) (EU Exit) Regulations 2020 of the United Kingdom, as amended and in force). The representation and undertakings in this Section&nbsp;1(nn) are only sought by and given to any Underwriter incorporated in or organized under the laws of the
Federal Republic of Germany to the extent that to do so would not result in a violation of or a conflict with the German Foreign Trade Regulation (Au&szlig;enwirtschaftsverordnung) and/or any similar anti-boycott law in Germany. The Issuers and the
Guarantor have not to their knowledge engaged in, and are not now knowingly engaged in, and will not engage in any dealings or transactions in violation of Sanctions with any person or entity that, at the time of such dealing or transaction, is or
was the subject or target of Sanctions or with or in any country or territory that is or was the target or subject of Sanctions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(oo) Neither the Guarantor nor any of its subsidiaries nor, to the knowledge of the Guarantor, any director, officer, agent,
employee or other person acting on behalf of the Guarantor or any of its subsidiaries, is (i)&nbsp;a person or entity that is organized under the laws of or ordinarily resident in Iran, North Korea or Myanmar, the three jurisdictions identified by
the Financial Action Task Force (&#147;<B><U>FATF</U></B>&#148;) in its February&nbsp;21, 2025 public statement as subject to a FATF call on its members and other jurisdictions (a)&nbsp;to apply enhanced due diligence measures proportionate to the
risks arising from the jurisdiction(s), and/or (b)&nbsp;to apply counter-measures to protect the international financial system from the ongoing and substantial money laundering and financing of terrorism risks emanating from the jurisdiction(s),
(each a &#147;<B><U>FATF Public Statement Jurisdiction</U></B>&#148;); or (ii)&nbsp;an entity controlled or majority owned by a person or entity organized under the laws of or ordinarily resident in a FATF Public Statement Jurisdiction. The
Guarantor will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity to fund any
activities or business of or with: (i)&nbsp;a FATF Public Statement Jurisdiction, (ii)&nbsp;any person or entity organized under the laws of or ordinarily resident in a FATF Public Statement Jurisdiction, or (iii)&nbsp;any entity controlled or
majority owned by a person or entity organized under the laws of or ordinarily resident in a FATF Public Statement Jurisdiction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(pp) Except as disclosed in the Guarantor&#146;s consolidated financial
statements included in the Disclosure Package and the Prospectus, neither the Guarantor nor any of its subsidiaries nor, to the knowledge of the Guarantor, any director, officer, agent, employee or affiliate acting on behalf of the Guarantor or any
of its subsidiaries has taken any action, directly or indirectly, that would result in a violation by such persons of the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the
&#147;<B><U>FCPA</U></B>&#148;), the U.K. Bribery Act 2010, or any other anti-corruption or anti-bribery law or regulation of any other jurisdiction to the extent such other laws or regulations are applicable; and the Guarantor, its subsidiaries
and, to the knowledge of the Guarantor, its affiliates have instituted and maintain policies and procedures reasonably designed to promote and achieve compliance with the FCPA, the U.K. Bribery Act 2010 and any other anti-corruption or anti-bribery
law or regulation of any other jurisdiction to the extent applicable. The Guarantor will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds directly
or indirectly in violation of the FCPA, the U.K. Bribery Act 2010, or any other anti-corruption or anti-bribery law or regulation of any other jurisdiction to the extent such other laws or regulations are applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(qq) The operations of each of the Guarantor and its subsidiaries are and have been conducted at all times in compliance in
all material respects with applicable financial recordkeeping and reporting requirements, including those of the U.S. Currency and Foreign Transactions Reporting Act of 1970, the Money Laundering, Terrorist Financing and Transfer of Funds
(Information on the Payer) Regulations 2017, as in force, as well as all applicable money laundering statutes of all jurisdictions where each of the Guarantor and its subsidiaries conducts business, the rules and regulations thereunder and any
related or similar rules, regulations or guidelines issued, administered or enforced by any governmental or regulatory agency (collectively, &#147;<B><U>Anti-Money Laundering Laws</U></B>&#148;) and no action, suit or proceeding by or before any
court or governmental or regulatory agency, authority or body or any arbitrator involving the Guarantor or any of its subsidiaries with respect to Anti-Money Laundering Laws is pending or, to the best of the Guarantor&#146;s knowledge, threatened.
The Guarantor will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds in any way not in compliance with Anti-Money Laundering Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(rr) None of the Guarantor or any of its affiliates has taken, directly or indirectly, any action designed to cause or result
in, or which has constituted or which might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Issuers in connection with the offering of the Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ss) To the extent that information is required to be publicly disclosed
under - Regulation (EU) No 596/2014 on market abuse, as amended and in force and any applicable delegated regulations thereunder, including, without limitation, Commission Delegated Regulation (EU) No 2016/1052 of 8&nbsp;March 2016 supplementing
Regulation (EU) 596/2014 with regard to regulatory technical standards for the conditions applicable to <FONT STYLE="white-space:nowrap">buy-back</FONT> programmes and stabilisation measures (the &#147;<B><U>Stabilising Rules</U></B>&#148;) before
stabilising transactions can be undertaken in compliance with the safe harbor provided under such Stabilising Rules, such information has been adequately publicly disclosed (within the meaning of the Stabilising Rules). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(tt) The interactive data in the eXtensible Business Reporting Language (&#147;<B><U>XBRL</U></B>&#148;) included or
incorporated by reference to the Registration Statement, fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(uu) Except as otherwise disclosed in the Disclosure Package and the Prospectus, or as would not reasonably be expected to
have a Material Adverse Effect, (i)&nbsp;to the knowledge of the Guarantor, since January&nbsp;1, 2022, there has been no security breach, unauthorized access or disclosure, or other compromise of the Issuers&#146;, the Guarantor&#146;s, nor their
respective subsidiaries&#146; owned or licensed information technology and computer systems, networks, hardware, software, confidential data and databases (including the confidential data and information of their respective customers, employees,
suppliers, vendors and any confidential third party data, in each case, maintained, processed or stored by the Issuers, the Guarantor, or their respective subsidiaries, and any such data processed or stored by third parties on behalf of the Issuers,
the Guarantor, or their respective subsidiaries), or equipment (collectively, &#147;<B><U>IT Systems and Data</U></B>&#148;); (ii) neither the Issuers, the Guarantor, nor their respective subsidiaries have, since January&nbsp;1, 2022, been notified
in writing of, and each of them have no knowledge of any event or condition that would reasonably be expected to result in, any security breach, unauthorized access or disclosure, or other compromise to their IT Systems and Data; and (iii)&nbsp;the
Issuers, the Guarantor and their respective subsidiaries are presently in material compliance with all applicable laws or statutes and all applicable judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory
authority, internal policies of the Issuers, the Guarantor and their respective subsidiaries and contractual obligations to which the Issuers, the Guarantor and their respective subsidiaries are bound, in each case, to the extent relating to the
privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification. Except as otherwise disclosed in the Disclosure Package or as would not reasonably be
expected to have a Material Adverse Effect, the Issuers, the Guarantor and their respective subsidiaries have implemented commercially reasonable or appropriate controls, policies, procedures, and technological safeguards designed to maintain and
protect the integrity, continuous operation and security of their IT Systems and Data. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Purchase, Sale and Delivery of Securities.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions and in reliance upon the representations and warranties herein set forth, (x)&nbsp;the
Euro Notes Issuer agrees (and the Guarantor agrees to cause the Euro Notes Issuer) to issue and sell to each Euro Underwriter, and each Euro Underwriter agrees, severally and not jointly, to purchase from the Euro Notes Issuer at a purchase price of
98.799% of the principal amount thereof, the respective principal amount of the 2031 Euro Notes as set forth opposite such Euro Underwriter&#146;s name in Part A of Schedule I hereto, and (y)&nbsp;the 2032 Dollar Notes Issuer agrees (and the
Guarantor agrees to cause the 2032 Dollar Notes Issuer) to issue and sell to each 2032 Dollar Underwriter, and each 2032 Dollar Underwriter agrees, severally and not jointly, to purchase from the 2032 Dollar Notes Issuer at a purchase price of
98.706% of the principal amount thereof, the respective principal amount of the 2032 Dollar Notes as set forth opposite such 2032 Dollar Underwriter&#146;s name in Part B of Schedule I hereto, and (z)&nbsp;the 2030 Dollar Notes Issuer agrees (and
the Guarantor agrees to cause the 2030 Dollar Notes Issuer) to issue and sell to each 2030 Dollar Underwriter, and each 2030 Dollar Underwriter agrees, severally and not jointly, to purchase from the 2030 Dollar Notes Issuer at a purchase price of
98.868% of the principal amount thereof, the respective principal amount of the 2030 Dollar Notes as set forth opposite such 2030 Dollar Underwriter&#146;s name in Part C of Schedule I hereto. The aggregate amount due to the Euro Notes Issuer from
the sale of the Euro Notes is hereinafter referred to as the &#147;<B><U>Euro Notes</U></B><B><U> purchase price</U></B>,&#148; the aggregate amount due to the 2032 Dollar Notes Issuer from the sale of the 2032 Dollar Notes is hereinafter referred
to as the &#147;<B><U>2032 Dollar Notes</U></B><B><U> purchase price</U></B>,&#148; and the aggregate amount due to the 2030 Dollar Notes Issuer from the sale of the 2030 Dollar Notes is hereinafter referred to as the &#147;<B><U>2030 Dollar Notes
purchase price</U></B>.&#148; Reference is hereby made to that certain dealer manager agreement dated May&nbsp;19, 2025 between certain of the Representatives (and/or their affiliates) and the Guarantor pursuant to which the Guarantor has agreed to
pay the dealer managers thereunder (or their respective affiliates) a fee of $2 for each $1,000 or &#128;2 for each &#128;1,000, as applicable, in principal amount of notes acquired pursuant to the tender offer referenced therein (the
&#147;<B><U>Tender Fee</U></B>&#148;). The Representatives severally agree to distribute the Tender Fee (net of any expenses or other costs) on a <I>pro rata </I>basis among the Underwriters (or their respective affiliates) in proportion of the
total aggregate principal amount of Securities set opposite the name of each Underwriter in Schedule I hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Delivery of and payment
for the Euro Securities shall be made at 9:00 a.m. (London time) on May&nbsp;28, 2025 and delivery of and payment for the 2032 Dollar Securities and the<B> </B>2030 Dollar Securities shall be made at 9:30 a.m. (New York time) on May&nbsp;28, 2025,
or such later date as the Representatives shall designate (the &#147;<B><U>Closing Date</U></B>&#148;), which date and time may be postponed by agreement among the Representatives, the Guarantor and each of the Issuers or as provided in
Section&nbsp;8 (such date and time of delivery and payment for the Securities being herein called the &#147;<B><U>Delivery Date</U></B>&#148;). Delivery of (i)&nbsp;the Euro Securities shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
be made to BNP PARIBAS on behalf of the Euro Underwriters against payment of the Euro Notes purchase price by BNP PARIBAS on behalf of the Euro Underwriters, (ii)&nbsp;the 2032 Dollar Securities
shall be made to J.P. Morgan SE on behalf of the 2032 Dollar Underwriters against payment of the 2032 Dollar Notes purchase price by J.P. Morgan SE on behalf of the 2032 Dollar Underwriters and (iii)&nbsp;the 2030 Dollar Securities shall be made to
J.P. Morgan SE on behalf of the 2030 Dollar Underwriters against payment of the 2030 Dollar Notes purchase price by J.P. Morgan SE on behalf of the 2030 Dollar Underwriters. Payment for (i)&nbsp;the Euro Securities shall be effected either by wire
transfer of immediately available funds to a bank account, the account details for which are to be provided by the Euro Notes Issuer or the Guarantor to the Euro Representatives at least two business days in advance of the Delivery Date, or by such
other manner of payment as may be agreed by the Euro Notes Issuer or the Guarantor and the Euro Representatives, (ii)&nbsp;the 2032 Dollar Securities shall be effected either by wire transfer of immediately available funds to an account with a bank
in The City of New York, the account number and the ABA number for such bank to be provided by the 2032 Dollar Notes Issuer or the Guarantor to the 2032 Dollar Representatives at least two business days in advance of the Delivery Date, or by such
other manner of payment as may be agreed by the 2032 Dollar Notes Issuer or the Guarantor and the Dollar Representatives and (iii)&nbsp;the 2030 Dollar Securities shall be effected either by wire transfer of immediately available funds to a bank
account, the account details for which are to be provided by the 2030 Notes Issuer or the Guarantor to the 2030 Dollar Representatives at least two business days in advance of the Delivery Date, or by such other manner of payment as may be agreed by
the 2030 Notes Issuer or the Guarantor and the 2030 Dollar Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Euro Notes Issuer will deliver
against payment of the Euro Notes purchase price the Euro Securities in the form of one or more permanent global certificates (the &#147;<B><U>Euro Global Securities</U></B>&#148;). The Euro Global Securities will be deposited on the Delivery Date
with, and registered in the name of a common depositary for, Euroclear Bank SA/NV (&#147;<B><U>Euroclear</U></B>&#148;) and for Clearstream Banking S.A. (&#147;<B><U>Clearstream</U></B>&#148;). Beneficial interests in the Euro Securities will be
shown on, and transfers thereof will be effected only through, records maintained in book-entry form by Euroclear or Clearstream, as applicable. The Euro Global Securities will be made available, at the request of the Euro Representatives, for
checking at least 24 hours prior to the Delivery Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The 2032 Dollar Notes Issuer will deliver against payment of
the 2032 Dollar Notes purchase price the 2032 Dollar Securities in the form of one or more permanent global certificates (the &#147;<B><U>2032 Dollar Global Securities</U></B>&#148;), registered in the name of Cede&nbsp;&amp; Co., as nominee for The
Depository Trust Company (&#147;<B><U>DTC</U></B>&#148;). Beneficial interests in the 2032 Dollar Securities will be shown on, and transfers thereof will be effected only through, records maintained in book-entry form by DTC and its participants,
Euroclear or Clearstream, as applicable. The 2032 Dollar Global Securities will be made available, at the request of the 2032 Dollar Representatives, for checking at least 24 hours prior to the Delivery Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The 2030 Dollar Notes Issuer will deliver against payment of the 2030
dollar purchase price the 2030 Dollar Securities in the form of one or more permanent global certificates (the &#147;<B><U>2030 Dollar Global Securities</U></B>&#148;), registered in the name of Cede&nbsp;&amp; Co., as nominee for DTC. Beneficial
interests in the 2030 Dollar Securities will be shown on, and transfers thereof will be effected only through, records maintained in book-entry form by DTC and its participants, Euroclear or Clearstream, as applicable. The 2030 Dollar Global
Securities will be made available, at the request of the 2030 Dollar Representatives, for checking at least 24 hours prior to the Delivery Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further
condition of the obligations of the Underwriters hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Solely for the purposes of the requirements of Article
9(8) of the MIFID Product Governance rules under EU Delegated Directive 2017/593 (the &#147;<B><U>Product Governance Rules</U></B>&#148;) regarding the mutual responsibilities of manufacturers under the Product Governance Rules: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) with respect to the Euro Securities: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(A) each of BofA Securities Europe SA, HSBC Continental Europe, Intesa Sanpaolo S.p.A. and J.P. Morgan SE (each a
&#147;<B><U>Euro EU Manufacturer</U></B>&#148; and together, the &#147;<B><U>Euro EU Manufacturers</U></B>&#148;) acknowledges to each other Euro EU Manufacturer that it understands the responsibilities conferred upon it under the Product Governance
Rules relating to each of the product approval process, the target market and the proposed distribution channels as applying to the Euro Securities and the related information set out in the Preliminary Prospectus, the Prospectus, the Registration
Statement and any other announcements in connection with the Euro Securities; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(B) the Euro Notes Issuer, the
Guarantor and the Euro Underwriters (other than the Euro EU Manufacturers) note the application of the Product Governance Rules and acknowledge the target market and distribution channels identified as applying to the Euro Securities by the Euro EU
Manufacturers and the related information set out in the Preliminary Prospectus, the Prospectus, the Registration Statement and any other announcements in connection with the Euro Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) with respect to the Dollar Securities: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(A) each of Intesa Sanpaolo S.p.A. and J.P. Morgan SE (each a &#147;<B><U>Dollar EU Manufacturer</U></B>&#148; and together,
the &#147;<B><U>Dollar EU Manufacturers</U></B>&#148;) acknowledges to each other Dollar EU Manufacturer that it understands the responsibilities conferred upon it under the Product Governance Rules relating to each of the product approval process,
the target market and the proposed distribution channels as applying to the Dollar Securities and the related information set out in the Preliminary Prospectus, the Prospectus, the Registration Statement and any other announcements in connection
with the Dollar Securities; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(B) each of the Dollar Notes Issuers, the Guarantor and the Dollar Underwriters (other
than the Dollar EU Manufacturer) note the application of the Product Governance Rules and acknowledge the target market and distribution channels identified as applying to the Dollar Securities by the Dollar EU Manufacturer and the related
information set out in the Preliminary Prospectus, the Prospectus, the Registration Statement and any other announcements in connection with the Dollar Securities. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Solely for the purposes of the requirements of 3.2.7R of the FCA Handbook Product Intervention and Product Governance
Sourcebook (the &#147;<B><U>UK MiFIR Product Governance Rules</U></B>&#148;) regarding the mutual responsibilities of manufacturers under the UK MiFIR Product Governance Rules: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) with respect to the Euro Securities: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(A) BNP PARIBAS (a &#147;<B><U>UK Euro Manufacturer</U></B>&#148;) acknowledges that it understands the responsibilities
conferred upon it under the UK MiFIR Product Governance Rules relating to each of the product approval process, the target market and the proposed distribution channels as applying to the Euro Securities and the related information set out in the
Preliminary Prospectus, the Prospectus, the Registration Statement and any other announcements in connection with the Euro Securities; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(B) the Euro Notes Issuer, Guarantor and the Euro Underwriters (other than the UK Euro Manufacturer) note the application of
the UK MiFIR Product Governance Rules and acknowledge the target market and distribution channels identified as applying to the Euro Securities by the UK Euro Manufacturer and the related information set out in the Preliminary Prospectus, the
Prospectus, the Registration Statement and any other announcements in connection with the Euro Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) with
respect to the Dollar Securities: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(A) HSBC Bank plc (the &#147;<B><U>UK Dollar Manufacturer</U></B>&#148;) acknowledges
that it understands the responsibilities conferred upon it under the UK MiFIR Product Governance Rules relating to each of the product approval process, the target market and the proposed distribution channels as applying to the Dollar Securities
and the related information set out in the announcements in connection with the Dollar Securities; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(B) each of the Dollar Notes Issuers, the Guarantor and the Dollar
Underwriters (other than the UK Dollar Manufacturer) note the application of the UK MiFIR Product Governance Rules and acknowledge the target market and distribution channels identified as applying to the Dollar Securities by the UK Dollar
Manufacturer and the related information set out in the announcements in connection with the Dollar Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) With
respect to the Euro Notes, BNP PARIBAS, or such other Euro Underwriter as the Euro Underwriters may agree, in its capacity as settlement bank (the &#147;<B><U>Settlement Bank</U></B>&#148;), on behalf of the Euro Underwriters, shall coordinate with
the Euro Notes Issuer to ensure settlement of the Euro Notes after the Execution Time. The Settlement Bank acknowledges that the Euro Notes represented by the Euro Global Securities will initially be credited free of payment to an account (the
&#147;<B><U>Commissionaire Account</U></B>&#148;) for the benefit of the Settlement Bank, the terms of which include a third-party beneficiary clause (&#145;<I>stipulation pour autrui</I>&#146;), with the Euro Notes Issuer as the third-party
beneficiaries, and which provide that such Euro Notes are to be delivered to investors only against payment of the net proceeds of the offering of the Euro Notes into the Commissionaire Account by the Settlement Bank on a delivery against payment
basis. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Settlement Bank acknowledges that (i)&nbsp;the Euro Notes represented by the Euro Global Securities shall
be held to the order of the Euro Notes Issuer as set out in clause (h)&nbsp;above and (ii)&nbsp;the net proceeds of the offering of the Euro Notes received in the Commissionaire Account from the Settlement Bank will be held on behalf of the Euro
Notes Issuer until such time as they are transferred to the Euro Notes Issuer&#146;s order. The Settlement Bank undertakes that the net proceeds of the offering in the Commissionaire Account will be transferred to the Euro Notes Issuer&#146;s order
immediately following receipt of such net proceeds in the Commissionaire Account (and for the avoidance of doubt, no later than the Closing Date). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Euro Notes Issuer acknowledges and accepts the benefit of the third-party beneficiary clause (&#145;<I>stipulation
pour autrui</I>&#146;) pursuant to the Belgian Civil Code, in the case of Euroclear, and the Luxembourg Civil Code, in the case of Clearstream, in each case in respect of the Commissionaire Account. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Further Agreements of the Issuers and the Guarantor</I></B><B>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Each of the Issuers (except for the agreements in Section&nbsp;3(a) and Section&nbsp;3(q), which are given by the Euro Notes Issuer only) and
the Guarantor, jointly and severally, further agree: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) To use reasonable efforts to have the Euro Notes admitted to
the Official List of Euronext Dublin and admitted to trading on the Global Exchange Market as soon as reasonably practicable; and (ii)&nbsp;to use reasonable efforts to maintain such listing for as long as any of the Euro Notes are outstanding. If
the Euro Notes cease to be listed on the Global Exchange Market of the Euronext Dublin, the Euro Notes Issuer and the Guarantor shall use reasonable efforts to relist the Euro Notes on the Euronext Dublin or to list the Euro Notes on such other
recognized stock exchange promptly and in any event before the date of the next interest payment on the Euro Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) To prepare the Prospectus in a form approved by the Representatives,
which approval shall not be unreasonably withheld or delayed, and to file such Prospectus pursuant to Rule 424(b) of the Rules and Regulations not later than Commission&#146;s close of business on the second Business Day following the execution and
delivery of this Agreement; (ii)&nbsp;to make no further amendment or any supplement to the Registration Statement or to the Prospectus (including to any Preliminary Prospectus) prior to the Delivery Date except as permitted or required herein;
(iii)&nbsp;to advise the Representatives, promptly after it receives notice thereof, of the time when any amendment to the Registration Statement has been filed or any supplement to the Prospectus or any amended Prospectus has been filed and to
furnish the Underwriters with copies thereof; (iv)&nbsp;to file promptly all reports required to be filed by the Issuer with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the
Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Securities; (v)&nbsp;to advise the Representatives, promptly after it receives notice thereof, of the issuance by the Commission of
any stop order or of any order preventing or suspending or objecting to the use of the Prospectus, of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding
for any such purpose, or of any request by the Commission for the amending or supplementing of the Registration Statement or the Prospectus or for additional information; and (vi)&nbsp;in the event of the issuance of any stop order or of any order
preventing or suspending or objecting to the use of the Prospectus or suspending any such qualification, to use promptly its reasonable best efforts to obtain its withdrawal, including, if necessary, by filing an amendment to the Registration
Statement or a new registration statement and using its best efforts to have such amendment or new registration statement declared effective as soon as practicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To prepare a final term sheet, containing solely a description of the Securities and the offering thereof, in a form
approved by the Representatives and to file such term sheet pursuant to Rule 433(d) of the Rules and Regulations within the time required by such Rule. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As soon as reasonably practicable, the Issuers will make generally available to their security holders and to the
Representatives an earnings statement (which need not be audited) covering a period of at least twelve months beginning with the first fiscal quarter of the Guarantor occurring after the &#147;effective date&#148; (as defined in Rule 158 under the
Securities Act) of the Registration Statement that will satisfy the provisions of Section&nbsp;11(a) and Rule 158 of the Securities Act; provided that the Guarantor will be deemed to have furnished such earnings statement to its security holders and
to the Representatives to the extent such earnings statement has been filed on the Commission&#146;s Electronic Data Gathering, Analysis and Retrieval System. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) (i) Each of the Issuers and the Guarantor agrees that, unless it
obtains or will obtain the prior written consent of the Representatives, and (ii)&nbsp;each Underwriter, severally and not jointly, agrees with the Issuers and the Guarantor that, unless it has obtained or will obtain, as the case may be, the prior
written consent of the Guarantor, it has not made and will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &#147;free writing prospectus&#148; (as defined in
Rule 405 of the Rules and Regulations) required to be filed by the Issuers or the Guarantor with the Commission or retained by the Issuers or the Guarantor under Rule 433 of the Rules and Regulations, other than the final term sheet prepared and
filed pursuant to Section&nbsp;3(c) hereto; provided that the prior written consent of the parties hereto shall be deemed to have been given in respect of the Free Writing Prospectuses included in Schedule II hereto and any electronic road show.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Any such free writing prospectus consented to by the Representatives or the Issuers and the Guarantor is hereinafter referred to as a
&#147;Permitted Free Writing Prospectus.&#148; The Issuers and the Guarantor agree that (x)&nbsp;they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y)&nbsp;they have
complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Rules and Regulations applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and
record keeping. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To furnish promptly to the Underwriters and to counsel for the Underwriters, Baker&nbsp;&amp;
McKenzie LLP, if requested a signed or facsimile signed copy of the Registration Statement as originally filed with the Commission, and each amendment thereto filed with the Commission, including all consents and exhibits filed therewith. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) If, at any time prior to the filing of the Prospectus pursuant to Rule 424(b) of the Rules and Regulations, any event
occurs as a result of which the Disclosure Package would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances under which they were made at such
time not misleading, the Issuers will (i)&nbsp;notify promptly the Representatives so that any use of the Disclosure Package may cease until it is amended or supplemented; (ii)&nbsp;amend or supplement the Disclosure Package to correct such
statement or omission; and (iii)&nbsp;supply any amendment or supplement to the Underwriters in such quantities as the Underwriters may reasonably request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) To deliver promptly to the Underwriters and counsel for the
Underwriters such number of the following documents as the Underwriters shall reasonably request: (i)&nbsp;conformed copies of the Registration Statement as originally filed with the Commission and each amendment thereto (in each case excluding
exhibits) and (ii)&nbsp;the Prospectus and any amended or supplemented Prospectus and any Preliminary Prospectus, and each Issuer Free Writing Prospectus, and, if the delivery of a prospectus is required at any time after the Execution Time in
connection with the offering or sale of the Securities (including in circumstances where such requirement may be satisfied pursuant to Rule 172 of the Rules and Regulations) and if at such time any events shall have occurred as a result of which the
Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading when such Prospectus is delivered, or, if, in the opinion of counsel for the Underwriters, for any other reason it shall be necessary to amend or supplement the Prospectus in order to comply with the Securities Act, to notify the
Representatives and, upon their request, to prepare and furnish without charge to the Underwriters and to any dealer in securities as many copies of an amended or supplemented Prospectus which will correct such statement or omission or effect such
compliance as the Underwriters may from time to time reasonably request. The Issuers will pay the expenses of printing and distributing to the Underwriters all such documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) During the time that delivery of a prospectus is required for the initial offering and sale of Securities (including in
circumstances where such requirement may be satisfied pursuant to Rule 172 of the Rules and Regulations), to file promptly with the Commission any amendment to the Registration Statement or the Prospectus or any supplement to the Prospectus, or new
registration statement, that may, in the reasonable judgment of the Issuers or the Representatives, be required by the Securities Act or that is requested by the Commission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) For so long as the delivery of a prospectus is required in connection with the initial offering or sale of the Securities
(including in circumstances where such requirement may be satisfied pursuant to Rule 172 of the Rules and Regulations), prior to filing with the Commission any amendment to the Registration Statement, supplement to the Prospectus, Prospectus
(including any Preliminary Prospectus), any document incorporated by reference in the Prospectus or any new registration statement, to furnish a copy thereof to the Underwriters and counsel for the Underwriters and obtain the consent of the
Representatives, which consent shall not unreasonably be withheld or delayed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) To apply the proceeds from the sale of
the Securities as set forth under &#147;<I>Use</I><I> </I><I>of</I><I> </I><I>Proceeds</I>&#148; in each of the Preliminary Prospectus and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) From the date hereof through the Closing Date, not to, directly or
indirectly, offer for sale, sell or otherwise dispose of (or enter into any transaction or device which is designed to, or could be expected to, result in the disposition or purchase by any person at any time in the future of), or announce an
offering of any debt securities issued or guaranteed by the Guarantor or either of the Issuers without the prior written consent of the Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Not to take, directly or indirectly, any action designed to cause or result in, or which has constituted or which might
reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Guarantor or either of the Issuers in connection with the offering of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) Cooperate with the Representatives, if necessary, for the qualification of the Securities for sale by the Underwriters
under the laws of such jurisdictions as the Representatives may designate (including Italy, Japan and certain provinces of Canada) and maintain such qualifications in effect so long as required for the sale of the Securities; provided that in no
event shall the Issuers be obligated to qualify to do business in any jurisdiction where it is not now so qualified or to take any action that would subject it to service of process in suits, other than those arising out of the offering or sale of
the Securities, in any jurisdiction where it is not now so subject or to subject itself to taxation in any jurisdiction wherein it would not otherwise be subject to tax but for the requirements of this paragraph. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) To take such steps as shall be necessary to ensure that neither of the Issuers nor the Guarantor shall become an
&#147;investment company&#148; within the meaning of such term under the Investment Company Act and the rules and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) To make reasonable commercial efforts so that neither of the Issuers will be deemed an Israeli tax resident. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) To use its reasonable best efforts to cause the Securities to be accepted for clearance and settlement through the
facilities of DTC, Euroclear or Clearstream, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) To hereby confirm the appointment of BNP PARIBAS in its
role as stabilizing manager (the &#147;<B><U>Euro Notes Stabilizing Manager</U></B>&#148;) as the central point responsible for adequate public disclosure of information, and handling any request from a competent authority, in accordance with
Article 6(5) of Commission Delegated Regulation (EU) 2016/1052 of 8&nbsp;March 2016 supplementing Regulation (EU) No.&nbsp;596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions
applicable to buyback programs and stabilization measures. The Euro Notes Stabilizing Manager for its own account may, to the extent permitted by applicable laws and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
directives, over-allot and effect transactions with a view to supporting the market price of the Euro Securities at a level higher than that which might otherwise prevail, but in doing so the
Euro Notes Stabilizing Manager shall act as principal and not as agent of the Euro Notes Issuer or the Guarantor and any loss resulting from overallotment and stabilization shall be borne, and any profit arising therefrom shall be beneficially
retained, by the Euro Notes Stabilizing Manager. However, there is no assurance that the Euro Notes Stabilizing Manager (or persons acting on behalf of the Euro Notes Stabilizing Manager) will undertake any stabilization action. Nothing contained in
this paragraph shall be construed so as to require the Euro Notes Issuer to issue, or the Guarantor to guarantee, in excess of &#128;1,000,000,000 in aggregate principal amount of the Euro Notes. Such stabilization, if commenced, may be discontinued
at any time and shall be conducted by the Euro Notes Stabilizing Manager in accordance with all applicable laws and directives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) To hereby confirm the appointment of J.P. Morgan SE in its role as stabilizing manager (the &#147;<B><U>2032 Dollar Notes
Stabilizing Manager</U></B>&#148;) as the central point responsible for adequate public disclosure of information, and handling any request from a competent authority, in accordance with Article 6(5) of Commission Delegated Regulation (EU) 2016/1052
of 8&nbsp;March 2016 supplementing Regulation (EU) No.&nbsp;596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buyback programs and stabilization measures. The 2032
Dollar Notes Stabilizing Manager for its own account may, to the extent permitted by applicable laws and directives, over-allot and effect transactions with a view to supporting the market price of the 2032 Dollar Securities at a level higher than
that which might otherwise prevail, but in doing so the 2032 Dollar Notes Stabilizing Manager shall act as principal and not as agent of the 2032 Dollar Notes Issuer or the Guarantor and any loss resulting from overallotment and stabilization shall
be borne, and any profit arising therefrom shall be beneficially retained, by the 2032 Dollar Notes Stabilizing Manager. However, there is no assurance that the 2032 Dollar Notes Stabilizing Manager (or persons acting on behalf of the 2032 Dollar
Notes Stabilizing Manager) will undertake any stabilization action. Nothing contained in this paragraph shall be construed so as to require the 2032 Dollar Notes Issuer to issue, or the Guarantor to guarantee, in excess of $500,000,000 in aggregate
principal amount of the 2032 Dollar Notes. Such stabilization, if commenced, may be discontinued at any time and shall be conducted by the 2032 Dollar Notes Stabilizing Manager in accordance with all applicable laws and directives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) To hereby confirm the appointment of J.P. Morgan SE in its role as stabilizing manager (the &#147;<B><U>2030 Dollar Notes
Stabilizing Manager</U></B>&#148;) as the central point responsible for adequate public disclosure of information, and handling any request from a competent authority, in accordance with Article 6(5) of Commission Delegated Regulation (EU) 2016/1052
of 8&nbsp;March 2016 supplementing Regulation (EU) No.&nbsp;596/2014 of the European </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buyback programs and stabilization measures. The 2030 Dollar Notes Stabilizing Manager
for its own account may, to the extent permitted by applicable laws and directives, over-allot and effect transactions with a view to supporting the market price of the 2030 Dollar Securities at a level higher than that which might otherwise
prevail, but in doing so the 2030 Dollar Notes Stabilizing Manager shall act as principal and not as agent of the 2030 Dollar Notes Issuer or the Guarantor and any loss resulting from overallotment and stabilization shall be borne, and any profit
arising therefrom shall be beneficially retained, by the 2030 Dollar Notes Stabilizing Manager. However, there is no assurance that the 2030 Dollar Notes Stabilizing Manager (or persons acting on behalf of the 2030 Dollar Notes Stabilizing Manager)
will undertake any stabilization action. Nothing contained in this paragraph shall be construed so as to require the 2030 Dollar Notes Issuer to issue, or the Guarantor to guarantee, in excess of $700,000,000 in aggregate principal amount of the
2030 Dollar Notes. Such stabilization, if commenced, may be discontinued at any time and shall be conducted by the 2030 Dollar Notes Stabilizing Manager in accordance with all applicable laws and directives. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Expenses.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Each of the Issuers (except for the expenses in Section&nbsp;4(f), which are applicable only to the Euro Notes Issuer) and the Guarantor,
jointly and severally, agree to pay: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the costs incident to the authorization, issuance, sale and delivery of the
Securities, and any taxes payable in that connection; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the costs incident to the preparation, printing and
distribution of the Prospectus and any amendment or supplement to the Prospectus (including any Preliminary Prospectus) or the Registration Statement and any Issuer Free Writing Prospectus, all as provided in this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the costs of producing and distributing the Operative Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) the fees and expenses of Kirkland&nbsp;&amp; Ellis LLP (&#147;<B><U>Kirkland</U></B>&#148;), Agmon with Tulchinsky Law
Firm (&#147;<B><U>Tulchinsky</U></B>&#148;), Van Doorne N.V. (&#147;<B><U>Van Doorne</U></B>&#148;) and Kesselman&nbsp;&amp; Kesselman; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the costs of distributing the terms of agreement relating to the organization of the underwriting syndicate and selling
group to the members thereof by mail or other means of communication and any transfer and stamp tax on the Securities due upon resale by the Underwriters of Securities purchased under this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) all fees incurred in connection with the listing of the Euro
Securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) all travel costs for personnel of the Issuers and the Guarantor (but excluding travel expenses of the
Underwriters relating to the road show) and the costs associated with any chartered plane used in connection with the road show; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) all fees and expenses incurred in connection with any rating of the Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the costs of preparing the Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) the fees and expenses (including fees and disbursements of counsel) of the Trustee, and the costs and charges of any
registrar, transfer agent, paying agent or calculation agent; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) all other costs and expenses incidental to the
performance of the obligations of the Issuers and the Guarantor under this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that, except as
provided in Sections 4, 7 and 10, the Underwriters shall pay their own costs and expenses, including the costs and expenses of their counsel, which costs and expenses shall be divided <I>pro rata </I>among the Underwriters in the proportions that
the total aggregate principal amount of Securities set opposite the name of each Underwriter in Schedule I bears to the total aggregate principal amount of Securities. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Conditions of the Underwriters&#146; Obligations.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The several obligations of the Underwriters hereunder are subject to the accuracy, at the Execution Time and on the Delivery Date, of the
representations and warranties of each of the Issuers and the Guarantor contained herein, to the performance by each of the Issuers and the Guarantor of its obligations hereunder, and to each of the following additional terms and conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) No Underwriter shall have discovered and disclosed to the Issuers or the Guarantor prior to or on the Delivery Date that
the Disclosure Package, the Prospectus or any amendment or supplement thereto contains any untrue statement of a fact which, in the opinion of counsel to the Underwriters, is material or omits to state any fact which is material and necessary in
order to make the statements therein, in the light of the circumstances under which they were made, not misleading or that the Registration Statement or any amendment thereto contains any untrue statement of a fact which, in the opinion of counsel
to the Underwriters, is material or omits to state any fact which is material and necessary to make the statements therein not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The Prospectus shall have been timely filed with the Commission in
accordance with Section&nbsp;3(a) of this Agreement; the final term sheet contemplated by Section&nbsp;3(c) hereof, and any other material required to be filed by the Guarantor pursuant to Rule 433(d) of the Rules and Regulations shall have been
filed with the Commission within the applicable time periods prescribed for such filings by Rule 433 of the Rules and Regulations; no stop order suspending the effectiveness of the Registration Statement or any part thereof or any notice that
objects to or would prevent its use shall have been issued and no proceeding for that purpose shall have been initiated or, to the knowledge of any of the parties hereto, threatened by the Commission; and any request of the Commission for inclusion
of additional information in the Registration Statement or the Prospectus or otherwise shall have been complied with in all material respects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) All corporate proceedings and other legal matters incident to the authorization, form and validity of the Operative
Documents and the Prospectus or any amendment or supplement thereto, and all other legal matters relating to the Operative Documents and the transactions contemplated thereby shall be satisfactory in all material respects to counsel to the
Underwriters, and the Issuers and the Guarantor shall have furnished to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Kirkland shall have furnished to the Underwriters their written opinion and negative assurance letter, as U.S. counsel to
the Issuers and the Guarantor, addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives, to the effect set forth in Exhibit A hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Van Doorne shall have furnished to the Underwriters their written opinion, as Netherlands counsel to the Issuers and the
Guarantor, addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives, to the effect set forth in Exhibit B hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) Tulchinsky shall have furnished to the Underwriters their written opinion, as Israeli counsel to the Guarantor, addressed
to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives, to the effect set forth in Exhibit C hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) David McAvoy, Executive Vice President and Chief Legal Officer of the Guarantor, shall have furnished to the Underwriters
his written opinion addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives, to the effect set forth in Exhibit D hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) Baker&nbsp;&amp; McKenzie LLP shall have furnished to the Underwriters
their written opinion and negative assurance letter, as U.S. counsel to the Underwriters, addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Herzog, Fox&nbsp;&amp; Neeman shall have furnished to the Underwriters their written opinion, as Israeli counsel to the
Underwriters, addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) Kesselman&nbsp;&amp; Kesselman, independent auditors for the Guarantor, shall have delivered to the Underwriters a
customary &#147;comfort letter&#148; in form and substance satisfactory to the Underwriters and dated as of the Execution Time (the &#147;<B><U>K&amp;K initial letter</U></B>&#148;), and a letter addressed to the Underwriters and dated as of the
Delivery Date (the &#147;<B><U>K&amp;K bring-down letter</U></B>&#148;), (i) confirming that they are the independent registered accounting firm with respect to the Guarantor within the meaning of the Securities Act and the Rules and Regulations,
(ii)&nbsp;stating, as of the date of the K&amp;K bring-down letter (or, with respect to matters involving changes or developments since the respective dates as of which specified financial information is given in the Prospectus or the Disclosure
Package, as of a date not more than five days prior to the date of the K&amp;K bring-down letter), the conclusions and findings of such firm with respect to the financial information and other matters covered by the K&amp;K initial letter and
(iii)&nbsp;confirming in all material respects the conclusions and findings set forth in the K&amp;K initial letter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k)
Each of the Issuers shall have furnished to the Representatives on the Delivery Date a certificate, dated such Delivery Date and delivered on behalf of each of the Issuers by one of its managing or supervisory directors or a duly authorized <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT> in form and substance satisfactory to the Underwriters, to the effect that the representations and warranties of such Issuer in Section&nbsp;1 are true and
correct as of the date given and as of such Delivery Date and such Issuer has complied in all material respects with all its agreements contained herein to be performed prior to or on such Delivery Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) The Guarantor shall have furnished to the Representatives on the Delivery Date a certificate, dated such Delivery Date
and delivered on behalf of the Guarantor by its chief executive officer, chief operating officer, chief financial officer or senior vice president, corporate treasurer, in form and substance satisfactory to the Underwriters, to the effect that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The representations and warranties of the Guarantor in Section&nbsp;1 are true and correct as of the date given and as of
such Delivery Date; and the Guarantor has complied in all material respects with all its agreements contained herein to be performed prior to or on such Delivery Date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) (A) Except as would not have a Material Adverse Effect, the Guarantor
has not sustained since the date of the latest audited financial statements incorporated by reference in the Prospectus any loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or
from any labor dispute or court or governmental action, order or decree, except (x)&nbsp;as set forth or contemplated in the Prospectus or the Disclosure Package (exclusive of any amendments or supplements thereto) and (y)&nbsp;for operating losses
incurred in the ordinary course of business, and (B)&nbsp;since such date there has not been any change in the capital stock or long-term debt of the Guarantor (except for issuances of shares of Ordinary Shares upon exercise of outstanding options
described in the Disclosure Package or pursuant to Authorized Grants), except as set forth or contemplated in the Prospectus or the Disclosure Package (exclusive of any amendments or supplements thereto), or any change, or any development involving
a prospective change, that would have a Material Adverse Effect; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Such officer has carefully examined the
Prospectus and the Disclosure Package, in such officer&#146;s opinion (A)&nbsp;each of the Prospectus and the Disclosure Package, as of its date and the Execution Time, respectively, did not include any untrue statement of a material fact and did
not omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, and (B)&nbsp;since the date of the Prospectus, no event has occurred which should have been
set forth in a supplement or amendment to the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m) Each of the Supplemental Indentures shall have been duly
executed and delivered by each of the Issuer party thereto, the Guarantor, the Trustee and any paying agent (if applicable); and the Notes and the Guarantees shall have been duly executed and delivered by each of the Issuer party thereto and the
Guarantor, respectively, and duly authenticated by the Trustee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n) The 2030 Dollar Indenture shall have been duly
executed and delivered by the 2030 Dollar Issuer, the Guarantor and the Trustee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(o) Since the date of the latest
audited financial statements incorporated by reference in the Disclosure Package (exclusive of any amendment or supplement thereto), there shall not have been (i)&nbsp;any material adverse change in the Guarantor&#146;s capital stock or long-term
debt, or (ii)&nbsp;any material adverse change or development involving a prospective material adverse change, in or affecting the condition (financial or otherwise), stockholders&#146; equity or results of operations of the Guarantor and its
subsidiaries, taken as a whole, except as set forth or contemplated in each of the most recent Preliminary Prospectus and the Prospectus (exclusive of any amendment or supplement thereto), the effect of which, in any such case described in clause
(i)&nbsp;or (ii), is, in the reasonable judgment of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
Representatives, so material and adverse as to make it impracticable or inadvisable to proceed with the sale or the delivery of the Securities being delivered on the Delivery Date on the terms
and in the manner contemplated in the Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto) and any Issuer Free Writing Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(p) Each of the Issuers and the Guarantor shall have furnished to the Representatives such further information, certificates
and documents as the Representatives may reasonably request to evidence compliance with the conditions set forth in this Section&nbsp;5. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(q) All opinions, letters, evidence and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in
compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel to the Underwriters. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Representations, Warranties and Agreements of Underwriters.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Each Underwriter, severally and not jointly, represents, warrants to and agrees with each of the Issuers and the Guarantor that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) It has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation
or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000 (the &#147;<B><U>FSMA</U></B>&#148;)) received by it in connection with the issue or sale of the Securities in
circumstances in which Section&nbsp;21(1) of the FSMA does not apply to the Issuers or the Guarantor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) It has
complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Securities in, from or otherwise involving the United Kingdom. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) It has not offered, sold or otherwise made available and will not offer, sell or otherwise make available any Securities
to any retail investor in the United Kingdom. For the purposes of this provision the expression &#147;retail investor&#148; means a person who is one (or more) of the following: (A)&nbsp;a retail client, as defined in point (8)&nbsp;of Article 2 of
Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (&#147;<B><U>EUWA</U></B>&#148;); or (B)&nbsp;a customer within the meaning of the provisions of the FSMA and any rules or regulations
made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8)&nbsp;of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the
EUWA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) It has not offered, sold or otherwise made available and will not
offer, sell or otherwise make available any Securities to any retail investor in the European Economic Area. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) For the
purposes of this provision the expression &#147;retail investor&#148; means a person who is one (or more) of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:22%; font-size:10pt; font-family:Times New Roman">1. a retail client as defined in point (11)&nbsp;of Article 4(1) of Directive 2014/65/EU (as amended, &#147;<B><U>MiFID
</U></B><B><U>II</U></B>&#148;); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:22%; font-size:10pt; font-family:Times New Roman">2. a customer within the meaning of Directive (EU) 2016/97 (as amended), where that
customer would not qualify as a professional client as defined in point (10)&nbsp;of Article 4(1) of MiFID II; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:22%; font-size:10pt; font-family:Times New Roman">3. not
a qualified investor as defined in Regulation (EU) 2017/1129. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) For the purposes of this provision the expression
&#147;offer&#148; includes the communication in any form and by any means of sufficient information on the terms of the offer and the Securities to be offered so as to enable an investor to decide to purchase or subscribe for the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Any offers in Canada will be made only under an exemption from the requirements to file a prospectus in the relevant
province of Canada in which the sale is made. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) Any offers in Italy will be made only to qualified investors
(<I>investitori qualificati</I>) as defined in Article 100 of Legislative Decree No.&nbsp;58 of 24&nbsp;February 1998, as amended (the &#147;<B><U>Financial Services Act</U></B>&#148;) and Article <FONT STYLE="white-space:nowrap">34-ter,</FONT>
first paragraph, letter b) of CONSOB Regulation No.&nbsp;11971 of 14&nbsp;May 1999, as amended from time to time (&#147;<B><U>Regulation No.</U></B><B><U></U></B><B><U>&nbsp;11971</U></B>&#148;); or (b)&nbsp;in other circumstances which are exempted
from the rules on public offerings pursuant to Article 100 of the Financial Services Act and Article <FONT STYLE="white-space:nowrap">34-ter</FONT> of Regulation No.&nbsp;11971. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) Any offers in the Netherlands will be made only to qualified investors as defined in Regulation (EU) 2017/1129, as
amended and as implemented from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) It will (i)&nbsp;purchase, accept delivery of and make payment for the
Securities outside the State of Israel and (ii)&nbsp;not offer or sell the Securities in the State of Israel, other than offers or sales to persons (A)&nbsp;who qualify as one of the types of investors listed in the First Addendum to the Israeli
Securities Law, subject to and in accordance with the requirements set forth in the First Addendum to the Israeli Securities Law, and (B)&nbsp;who have confirmed in writing that they are purchasing the Securities for their own account
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
and not with a view to, or for resale in connection with, any distribution thereof; except, to the extent permitted under the First Addendum to the Israeli Securities Law, for resale to qualified
investors of the types listed therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) It will comply with applicable laws and regulations in each jurisdiction in
which it acquires, offers, sells or delivers Securities, or has in its possession or distributes any Free Writing Prospectus, the Disclosure Package, the Preliminary Prospectus and the Prospectus. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Indemnification and Contribution</I></B><B>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the Issuers and the Guarantor, jointly and severally, shall indemnify and hold harmless each Underwriter, its
officers, employees, agents, affiliates and each person, if any, who controls any Underwriter within the meaning of the Securities Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof
(including, but not limited to, any loss, claim, damage, liability or action relating to purchases and sales of the Securities), to which that Underwriter, officer, employee, agent, affiliate or controlling person may become subject, insofar as such
loss, claim, damage, liability or action arises out of, or is based upon: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any untrue statement or alleged untrue
statement of a material fact contained in the Prospectus, the Preliminary Prospectus, the Registration Statement, any Issuer Free Writing Prospectus, any materials used by the Issuers or the Guarantor in meetings with investors (including any
electronic road show), or the information contained in the final term sheet required to be prepared and filed pursuant to Section&nbsp;3(c) hereto, or in any amendment or supplement thereto; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the omission or alleged omission to state therein any material fact necessary to make the statements therein not
misleading, and shall reimburse each Underwriter and each such officer, employee, agent, affiliate and controlling person promptly upon demand for any legal or other expenses reasonably incurred by that Underwriter, officer, employee, agent,
affiliate or controlling person in connection with investigating or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are incurred; <U>provided</U>, <U>however</U>, that neither of the
Issuers nor the Guarantor shall be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of, or is based upon, any untrue statement or alleged untrue statement or omission or alleged omission made in
the Preliminary Prospectus, the Prospectus, the Registration Statement, any Issuer Free Writing Prospectus, any materials used by the Issuers or the Guarantor in meetings with investors (including any electronic road show), or the information
contained in the final term sheet required to be prepared and filed pursuant to Section&nbsp;3(c) hereto, or in any such amendment or supplement thereto, in reliance upon and in conformity with the written information furnished to the Issuers or the
Guarantor by or on behalf of any Underwriter specifically for inclusion therein and described in Section&nbsp;7(e). The foregoing indemnity agreement is in addition to any liability that the Issuers or the Guarantor may otherwise have to any
Underwriter or to any officer, employee, agent, affiliate or controlling person of that Underwriter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Underwriter, severally and not jointly, shall indemnify and hold
harmless, each of the Issuers and the Guarantor, its officers and directors, agents, employees and each person, if any, who controls each of the Issuers or the Guarantor within the meaning of the Securities Act from and against any loss, claim,
damage or liability, joint or several, or any action in respect thereof, to which the Issuers or the Guarantor or their respective directors, officers, agents, employees or controlling persons may become subject, insofar as such loss, claim, damage,
liability or action arises out of, or is based upon: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any untrue statement or alleged untrue statement of a material
fact contained in the Prospectus, the Preliminary Prospectus, any Issuer Free Writing Prospectus or the information contained in the final term sheet required to be prepared and filed pursuant to Section&nbsp;3(c) hereto, or in any amendment or
supplement thereto; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the omission or alleged omission to state therein any material fact necessary to make the
statements therein not misleading, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">but in each case only to the extent that such untrue statement or alleged untrue
statement or omission or alleged omission was made in reliance upon and in conformity with the written information furnished to the Issuers or the Guarantor by or on behalf of that Underwriter specifically for inclusion therein and described in
Section&nbsp;7(e), and shall reimburse the Issuers and the Guarantor and any such director, officer, agent, employee or controlling person promptly upon demand for any legal or other expenses reasonably incurred by the Issuers or the Guarantor or
any such director, officer, agent, employee or controlling person in connection with investigating or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are incurred. The foregoing indemnity
agreement is in addition to any liability which any Underwriter may otherwise have to the Issuers, the Guarantor or any such director, officer, agent, employee or controlling person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Promptly after receipt by an indemnified party under this Section&nbsp;7 of notice of any claim or the commencement of any
action, the indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under this Section&nbsp;7, notify the indemnifying party in writing of the claim or the commencement of that action; provided, however,
that the failure to notify the indemnifying party shall not relieve it from any liability which it may have under this Section&nbsp;7 except to the extent it has been materially prejudiced by such failure; and, provided, further, that the failure to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
notify the indemnifying party shall not relieve it from any liability which it may have to an indemnified party otherwise than under this Section&nbsp;7. If any such claim or action shall be
brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying
party, to assume the defense thereof with counsel satisfactory to the indemnified party. After notice from the indemnifying party to the indemnified party of its election to assume the defense of such claim or action, the indemnifying party shall
not be liable to the indemnified party under this Section&nbsp;7 for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof other than reasonable costs of investigation; provided, however,
that the Underwriters shall have the right to employ counsel to represent jointly the Underwriters and their respective officers, employees, agents, affiliates and controlling persons who may be subject to liability arising out of any claim in
respect of which indemnity may be sought by the Underwriters against the Issuers under this Section&nbsp;7, if the Underwriters shall have reasonably concluded that there may be one or more legal defenses available to the Underwriters and their
respective officers, employees, agents, affiliates and controlling persons that are different from or additional to those available to the Issuers and the Guarantor and their respective officers, directors, employees, agents, affiliates and
controlling persons, and the reasonable fees and expenses of a single separate counsel shall be paid, jointly and severally, by each of the Issuers and the Guarantor. No indemnifying party shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) without the prior written consent of the indemnified parties (which consent shall not be unreasonably withheld) settle or
compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are
actual or potential parties to such claim or action) unless such settlement, compromise or consent (A)&nbsp;includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding and
(B)&nbsp;does not include any statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party, or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) be liable for any settlement of any such action effected without its written consent (which consent shall not be
unreasonably withheld), but if settled with its written consent or if there be a final judgment for the plaintiff in any such action, the indemnifying party agrees to indemnify and hold harmless any indemnified party from and against any loss or
liability by reason of such settlement or judgment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the indemnification provided for in this Section&nbsp;7 shall for
any reason be unavailable or insufficient to hold harmless an indemnified party under Section&nbsp;7(a) or 7(b) in respect of any loss, claim, damage or liability, or any action in respect thereof, referred to therein, each indemnifying party shall,
in lieu of indemnifying such indemnified party, contribute to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) in such proportion as shall be appropriate to reflect the relative benefits received by the Issuers and the Guarantor on
the one hand and the Underwriters on the other from the offering of the Securities, or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) if the allocation provided by
clause 7(d)(i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause 7(d)(i) but also the relative fault of the Issuers and the Guarantor on the one hand and the
Underwriters on the other with respect to the statements or omissions or alleged statements or alleged omissions that resulted in such loss, claim, damage or liability (or action in respect thereof), as well as any other relevant equitable
considerations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">The relative benefits received by the Issuers and the Guarantor on the one hand and the Underwriters on
the other with respect to such offering shall be deemed to be in the same proportion as the total net proceeds from the offering of the Securities purchased under this Agreement (before deducting expenses) received by the Issuers on the one hand,
and the total discounts and commissions received by the Underwriters with respect to the Securities purchased under this Agreement, on the other hand, bear to the total gross proceeds from the offering of the Securities under this Agreement, in each
case as set forth in the table on the cover page of the Prospectus. The relative fault shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact
relates to information supplied by the Issuers or the Guarantor on the one hand or the Underwriters on the other, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or
omission. The Issuers, the Guarantor and the Underwriters agree that it would not be just and equitable if the amount of contributions pursuant to this Section&nbsp;7(d) were to be determined by <U>pro rata</U> allocation (even if the Underwriters
were treated as one entity for such purpose) or by any other method of allocation which does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim,
damage or liability, or action in respect thereof, referred to above in this Section&nbsp;7(d) shall be deemed to include, for purposes of this Section&nbsp;7(d), any legal or other expenses reasonably incurred by such indemnified party in
connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section&nbsp;7(d), no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the
Securities resold by it in the initial placement of such Securities were offered to investors exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or
omission or alleged omission. No person guilty of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Underwriters&#146; obligations to contribute as provided in this Section&nbsp;7(d) are several in proportion to their respective purchase obligations and not joint. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Underwriters severally confirm that the statements with respect to the delivery of the Securities set forth on the
cover page of the Prospectus and the Preliminary Prospectus and the first paragraph under the <FONT STYLE="white-space:nowrap">sub-caption</FONT> &#147;<I>Price Stabilization and Short Positions</I>&#148; and the allocation table under the caption
&#147;<I>Underwriting</I>&#148; in the Prospectus and the most recent Preliminary Prospectus are correct and constitute the only information furnished in writing to the Issuers and the Guarantor by or on behalf of the Underwriters specifically for
inclusion in the most recent Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus or the information contained in the final term sheet required to be prepared and filed pursuant to Section&nbsp;3(c) hereof. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Defaulting Underwriters.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">If, on the Delivery Date, any Euro Underwriter defaults in the performance of its obligations under this Agreement, the
remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriters shall be obligated to purchase the aggregate principal amount of such series of Euro Securities which the defaulting Euro Underwriter agreed but failed to purchase on
such Delivery Date in the respective proportions which the total aggregate principal amount of such series of Euro Securities set opposite the name of each remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriter in Part A
of Schedule I hereto bears to the total aggregate principal amount of such series of Euro Securities set opposite the names of all the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriters in Part A of Schedule I hereto;
<U>provided</U>, <U>however</U>, that the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriters shall not be obligated to purchase any such series of Euro Securities on such Delivery Date if the total aggregate principal
amount of such series of Euro Securities which the defaulting Euro Underwriters agreed but failed to purchase on such date exceeds 10.0% of the total aggregate principal amount of such series of Euro Securities to be purchased on such Delivery Date,
and any remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriter shall not be obligated to purchase more than 110.0% of the aggregate principal amount of any series of Euro Securities which it agreed to purchase on such
Delivery Date pursuant to the terms of Section&nbsp;2. If the foregoing maximums are exceeded, the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriters, or those other purchasers satisfactory to the Euro Underwriters
who so agree, shall have the right, but shall not be obligated, to purchase on such Delivery Date, in such proportion as may be agreed upon among them, the total aggregate principal amount of any series of Euro Securities to be purchased on such
Delivery Date. If the remaining Euro Underwriters or other purchasers satisfactory to the Euro Underwriters do not elect to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
purchase on such Delivery Date the aggregate principal amount of the series of Euro Securities which the defaulting Euro Underwriters agreed but failed to purchase, this Agreement shall terminate
with respect to the Euro Underwriters without liability on the part of any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriters and the Issuers and the Guarantor, except that the Issuers and the Guarantor will continue to be
liable for the payment of expenses to the extent set forth in Sections 4 and 10. As used in this Agreement, the term &#147;<B><U>Euro Underwriter</U></B>&#148; includes, for all purposes of this Agreement unless the context requires otherwise, any
party not listed in Part A of Schedule I hereto who, pursuant to this Section&nbsp;8, purchases any series of Euro Securities which a defaulting Euro Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">If, on the Delivery Date, any 2032 Dollar Underwriter defaults in the performance of its obligations under this Agreement, the
remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> 2032 Dollar Underwriters shall be obligated to purchase the aggregate principal amount of such series of 2032 Dollar Securities which the defaulting 2032 Dollar Underwriter agreed but
failed to purchase on such Delivery Date in the respective proportions which the total aggregate principal amount of such series of 2032 Dollar Securities set opposite the name of each remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT>
2032 Dollar Underwriter in Part B of Schedule I hereto bears to the total aggregate principal amount of such series of 2032 Dollar Securities set opposite the names of all the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Dollar
Underwriters in Part B of Schedule I hereto; <U>provided</U>, <U>however</U>, that the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriters shall not be obligated to purchase any such series of 2032 Dollar Securities
on such Delivery Date if the total aggregate principal amount of such series of 2032 Dollar Securities which the defaulting Dollar Underwriters agreed but failed to purchase on such date exceeds 10.0% of the total aggregate principal amount of such
series of 2032 Dollar Securities to be purchased on such Delivery Date, and any remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriter shall not be obligated to purchase more than 110.0% of the aggregate principal amount
of any series of 2032 Dollar Securities which it agreed to purchase on such Delivery Date pursuant to the terms of Section&nbsp;2. If the foregoing maximums are exceeded, the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> 2032
Dollar Underwriters, or those other purchasers satisfactory to the 2032 Dollar Underwriters who so agree, shall have the right, but shall not be obligated, to purchase on such Delivery Date, in such proportion as may be agreed upon among them, the
total aggregate principal amount of any series of 2032 Dollar Securities to be purchased on such Delivery Date. If the remaining 2032 Dollar Underwriters or other purchasers satisfactory to the 2032 Dollar Underwriters do not elect to purchase on
such Delivery Date the aggregate principal amount of the series of 2032 Dollar Securities which the defaulting 2032 Dollar Underwriters agreed but failed to purchase, this Agreement shall terminate with respect to the 2032 Dollar Underwriters
without liability on the part of any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> 2032 Dollar Underwriters and the Issuers and the Guarantor, except that the Issuers and the Guarantor will continue to be liable for the payment of expenses
to the extent set forth in Sections 4 and 10. As used in this Agreement, the term &#147;<B><U>2032 Dollar </U></B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
<B><U>Underwriter</U></B>&#148; includes, for all purposes of this Agreement unless the context requires otherwise, any party not listed in Part B of Schedule I hereto who, pursuant to this
Section&nbsp;8, purchases any series of 2032 Dollar Securities which a defaulting 2032 Dollar Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">If, on the Delivery Date, any 2030 Dollar Underwriter defaults in the performance of its obligations under this Agreement,
the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> 2030 Dollar Underwriters shall be obligated to purchase the aggregate principal amount of such series of 2030 Dollar Securities which the defaulting 2030 Dollar Underwriter agreed
but failed to purchase on such Delivery Date in the respective proportions which the total aggregate principal amount of such series of 2030 Dollar Securities set opposite the name of each remaining
<FONT STYLE="white-space:nowrap">non-defaulting</FONT> 2030 Dollar Underwriter in Part C of Schedule I hereto bears to the total aggregate principal amount of such series of 2030 Dollar Securities set opposite the names of all the remaining <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriters in Part C of Schedule I hereto; <U>provided</U>, <U>however</U>, that the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriters shall not be
obligated to purchase any such series of 2030 Dollar Securities on such Delivery Date if the total aggregate principal amount of such series of 2030 Dollar Securities which the defaulting Dollar Underwriters agreed but failed to purchase on such
date exceeds 10.0% of the total aggregate principal amount of such series of 2030 Dollar Securities to be purchased on such Delivery Date, and any remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriter shall not be
obligated to purchase more than 110.0% of the aggregate principal amount of any series of 2030 Dollar Securities which it agreed to purchase on such Delivery Date pursuant to the terms of Section&nbsp;2. If the foregoing maximums are exceeded, the
remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> 2030 Dollar Underwriters, or those other purchasers satisfactory to the 2030 Dollar Underwriters who so agree, shall have the right, but shall not be obligated, to purchase on such
Delivery Date, in such proportion as may be agreed upon among them, the total aggregate principal amount of any series of 2030 Dollar Securities to be purchased on such Delivery Date. If the remaining 2030 Dollar Underwriters or other purchasers
satisfactory to the 2030 Dollar Underwriters do not elect to purchase on such Delivery Date the aggregate principal amount of the series of 2030 Dollar Securities which the defaulting 2030 Dollar Underwriters agreed but failed to purchase, this
Agreement shall terminate with respect to the 2030 Dollar Underwriters without liability on the part of any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> 2030 Dollar Underwriters and the Issuers and the Guarantor, except that the Issuers
and the Guarantor will continue to be liable for the payment of expenses to the extent set forth in Sections 4 and 10. As used in this Agreement, the term &#147;<B><U>2030 Dollar Underwriter</U></B>&#148; includes, for all purposes of this Agreement
unless the context requires otherwise, any party not listed in Part C of Schedule I hereto who, pursuant to this Section&nbsp;8, purchases any series of 2030 Dollar Securities which a defaulting 2030 Dollar Underwriter agreed but failed to purchase.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:13%; font-size:10pt; font-family:Times New Roman">Nothing contained herein shall relieve a defaulting Underwriter of any
liability it may have to the Issuers or the Guarantor for damages caused by its default. If other purchasers are obligated or agree to purchase the Securities of a defaulting or withdrawing Underwriter, either the remaining <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Issuers may postpone the Delivery Date for up to seven full business days in order to effect any changes in the Prospectus or in any other document or arrangement that, in the
opinion of counsel to the Issuers and the Guarantor or counsel to the Underwriters, may be necessary. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Termination.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The obligations of the Underwriters hereunder may be terminated by the Representatives by notice given to and received by the Issuers and the
Guarantor prior to delivery of and payment for the Securities, after the execution and delivery of this Agreement and prior to the Delivery Date, any of the following events shall have occurred (i)&nbsp;trading in securities generally on the New
York Stock Exchange, or trading in any securities of the Guarantor on any exchange shall have been suspended or minimum prices shall have been established on any such exchange or market by the Commission, by such exchange or by any other regulatory
body or governmental authority having jurisdiction; (ii)&nbsp;a banking moratorium shall have been declared by United States federal or New York State authorities or a material disruption shall have occurred in commercial banking or securities
settlement or clearance services in the United States; (iii)&nbsp;there shall have occurred any outbreak or escalation in hostilities involving the United States, or there shall have been a declaration of a national emergency or war by the United
States or The Netherlands; (iv)&nbsp;the rating accorded the Guarantor&#146;s debt securities shall have been downgraded by any &#147;nationally recognized statistical rating organization,&#148; as that term is defined in Section&nbsp;3(a)(62) of
the Exchange Act, or such an organization shall have made any public announcement that it has under surveillance or review, with possible negative implications for a downgrade, its rating of any of the Guarantor&#146;s debt securities; or
(v)&nbsp;there shall have occurred such a material adverse change in general economic, political or financial conditions (or the effect of international conditions on the financial markets in the United States, The Netherlands or Israel shall be
such) as to make it, with respect to the events in clause (iii)&nbsp;or (v) in the sole judgment of the Representatives, impracticable or inadvisable to proceed with the offering or delivery of the Securities being delivered on such Delivery Date on
the terms and in the manner contemplated in the Disclosure Package and the Prospectus. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Reimbursement of Underwriters&#146; Expenses.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">If (a)&nbsp;either of the Issuers and the Guarantor shall fail to tender the Securities for delivery to the Underwriters for any reason
permitted under this Agreement or (b)&nbsp;the Underwriters shall decline to purchase the Securities because of any failure or refusal on the part of either of the Issuers or the Guarantor to comply with the terms or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
to fulfill any of the conditions of this Agreement or if either of the Issuers or the Guarantor shall be unable to perform its obligations under this Agreement, the relevant Issuer(s) and the
Guarantor, jointly and severally, shall reimburse the Underwriters for the fees and expenses of their counsel and for such other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses as shall have
been incurred by them in connection with this Agreement and the proposed purchase of the Securities, and upon demand the relevant Issuer(s) shall pay the full amount thereof to the Underwriters. If this Agreement is terminated pursuant to
Section&nbsp;8 by reason of the default of one or more Underwriters, the relevant Issuer(s) shall not be obligated to reimburse any defaulting Underwriter on account of those expenses. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notices, etc. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">All statements, requests, notices and agreements hereunder shall be in writing, and: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) if to the Euro Underwriters or the Euro Representatives, shall be delivered or sent by mail to: BNP PARIBAS, 16, boulevard
des Italiens, 75009 Paris, France, Attention: High Yield Desk (email: dl.syndsupportbonds@uk.bnpparibas.com); BofA Securities Europe SA, 51 rue La Bo&eacute;tie, 75008 Paris, France, Attention: High Yield Syndicate Desk (Tel: +33 18 770 0000, email:
levfin_hy_paris@bofa.com); HSBC Continental Europe, 38, avenue Kl&eacute;ber, 75116 Paris, France, Attention: DAJ Global Banking, email: transaction.management@hsbcib.com; Intesa Sanpaolo S.p.A., Divisione IMI Corporate&nbsp;&amp; Investment
Banking, Via Manzoni, 4 &#150; 20121, Milan, Italy, Attention: DCM HY Intesa Sanpaolo, email: <FONT STYLE="white-space:nowrap">IMI-DCM.HY@intesasanpaolo.com;</FONT> J.P. Morgan SE, Taunustor 1 (TaunusTurm), 60310 Frankfurt am Main, Germany,
Attention: Head of EMEA Capital Markets Group, email: Head_of_EMEA_DCMG@jpmorgan.com; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) if to the 2032 Dollar
Underwriters or the Dollar Representatives, shall be delivered or sent by mail to: BNP Paribas Securities Corp., 787 Seventh Avenue, New York, New York 10019, United States of America, Attention: Syndicate Desk (email:
DL.US.Debt.Syndicate.Support@us.bnpparibas.com); BofA Securities, Inc., 114 West 47<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Street, 7<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">NY8-114-07-01,</FONT></FONT></FONT> New York, New York 10036, United States of America, Attention: High Yield Legal Department, email: BofA_HY_Legal_Notices@bofa.com; HSBC Bank plc, 8
Canada Square, London E14 5HQ, United Kingdom, Attention: Head of DCM Legal, email: transaction.management@hsbcib.com; Intesa Sanpaolo S.p.A., Divisione IMI Corporate&nbsp;&amp; Investment Banking, Via Manzoni, 4 &#150; 20121, Milan, Italy,
Attention: DCM HY Intesa Sanpaolo, email: <FONT STYLE="white-space:nowrap">IMI-DCM.HY@intesasanpaolo.com;</FONT> J.P. Morgan SE, Taunustor 1 (TaunusTurm), 60310 Frankfurt am Main, Germany, Attention: Head of EMEA Capital Markets Group, email:
Head_of_EMEA_DCMG@jpmorgan.com; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) if to the 2030 Dollar Underwriters or the Dollar Representatives, shall
be delivered or sent by mail to: BNP Paribas Securities Corp., 787 Seventh Avenue, New York, New York 10019, United States of America, Attention: Syndicate Desk (email: DL.US.Debt.Syndicate.Support@us.bnpparibas.com); BofA Securities, Inc., 114 West
47th Street, 7th Floor, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">NY8-114-07-01,</FONT></FONT></FONT> New York, New York 10036, United States of America, Attention: High Yield Legal
Department, email: BofA_HY_Legal_Notices@bofa.com; HSBC Bank plc, 8 Canada Square, London E14 5HQ, United Kingdom, Attention: Head of DCM Legal, email: transaction.management@hsbcib.com; Intesa Sanpaolo S.p.A., Divisione IMI Corporate&nbsp;&amp;
Investment Banking, Via Manzoni, 4 &#150; 20121, Milan, Italy, Attention: DCM HY Intesa Sanpaolo, email: <FONT STYLE="white-space:nowrap">IMI-DCM.HY@intesasanpaolo.com;</FONT> J.P. Morgan SE, Taunustor 1 (TaunusTurm), 60310 Frankfurt am Main,
Germany, Attention: Head of EMEA Capital Markets Group, email: Head_of_EMEA_DCMG@jpmorgan.com; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) if to the Guarantor,
shall be delivered or sent by mail or facsimile transmission to Teva Pharmaceutical Industries Limited, 124 Dvora Hanevi&#146;a Street, Tel Aviv, 6944020, Israel, Attention: Stephen Harper (Fax: *****), with copies (which shall not constitute
notice) to: (i)&nbsp;Teva Pharmaceuticals USA, Inc., 400 Interpace Parkway, Building A Parsippany, New Jersey 07054, Attention: David McAvoy; and (ii)&nbsp;Kirkland&nbsp;&amp; Ellis LLP, 601 Lexington Avenue, New York, New York 10022, Attention:
Ross Leff and Christie Mok (Fax: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-446-4900);</FONT></FONT> and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) if to the Euro Notes Issuer, shall be delivered or sent by mail or facsimile transmission to Teva Pharmaceutical Finance
Netherlands II B.V., Busweg 1, 2031 DA, Haarlem, The Netherlands, Attention: Managing Director, with copies (which shall not constitute notice) to: (i)&nbsp;c/o Teva Pharmaceuticals USA, Inc., 400 Interpace Parkway, #3 Parsippany, New Jersey 07054,
Attention: David McAvoy and (ii)&nbsp;Kirkland&nbsp;&amp; Ellis LLP, 601 Lexington Avenue, New York, New York 10022, Attention: Ross Leff and Christie Mok (Fax:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-446-4900);</FONT></FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) if to the 2032 Dollar
Notes Issuer, shall be delivered or sent by mail or facsimile transmission to Teva Pharmaceutical Finance Netherlands III B.V., Busweg 1, 2031 DA, Haarlem, The Netherlands, Attention: Managing Director, with copies (which shall not constitute
notice) to: (i)&nbsp;c/o Teva Pharmaceuticals USA, Inc., 400 Interpace Parkway, #3 Parsippany, New Jersey 07054, Attention: David McAvoy and (ii)&nbsp;Kirkland&nbsp;&amp; Ellis LLP, 601 Lexington Avenue, New York, New York 10022, Attention: Ross
Leff and Christie Mok (Fax: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-446-4900);</FONT></FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) if to the 2030 Dollar Notes Issuer, shall be delivered or sent by mail
or facsimile transmission to Teva Pharmaceutical Finance Netherlands IV B.V., Busweg 1, Haarlem, 2031 DA, Netherlands, Attention: Managing Director, with copies (which shall not constitute notice) to: (i)&nbsp;c/o Teva Pharmaceuticals USA, Inc., 400
Interpace Parkway, #3 Parsippany, New Jersey 07054, Attention: David McAvoy and (ii)&nbsp;Kirkland&nbsp;&amp; Ellis LLP, 601 Lexington Avenue, New York, New York 10022, Attention: Ross Leff and Christie Mok (Fax: <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">212-446-4900);</FONT></FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that any notice to an Underwriter pursuant to
Section&nbsp;7(c) shall be delivered or sent by mail or facsimile transmission to each such Underwriter, which address will be supplied to any other party hereto by the Representatives upon request. Any such statements, requests, notices or
agreements shall take effect at the time of receipt thereof. The Issuers and the Guarantor shall be entitled to act and rely upon any request, consent, notice or agreement given or made on behalf of the Underwriters by the Representatives. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Persons Entitled to Benefit of Agreement.</I></B><B></B><B><I> </I></B><B>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">This Agreement shall inure to the benefit of and be binding upon the Underwriters, the Issuers, the Guarantor and
their respective successors. This Agreement and the terms and provisions hereof are for the sole benefit of only those persons, except that the representations, warranties, indemnities and agreements of the Issuers and the Guarantor contained in
this Agreement shall also be deemed to be for the benefit of the officers, employees, agents and affiliates of each Underwriter and the person or persons, if any, who control each Underwriter within the meaning of Section&nbsp;15 of the Securities
Act and any indemnity agreement of the Underwriters contained in Section&nbsp;7(b) of this Agreement shall be deemed to be for the benefit of directors, officers, employees, agents and affiliates of the Issuers and the Guarantor, and any person
controlling the Issuers or the Guarantor within the meaning of Section&nbsp;15 of the Securities Act. Nothing contained in this Agreement is intended or shall be construed to give any person, other than the persons referred to in this
Section&nbsp;12, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Survival. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The respective indemnities, representations, warranties and agreements of the Issuers, the Guarantor and the Underwriters contained in this
Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall survive the delivery of and payment for the Securities and shall remain in full force and effect, regardless of any termination or cancellation of this
Agreement or any investigation made by or on behalf of any of them or any person controlling any of them. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Transfers to EU Affiliates.</I></B><B></B><B><I> </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this Agreement, each Underwriter (whether it is an original party to this Agreement or a party to
whom this Agreement has been previously transferred pursuant to this paragraph) shall be entitled to assign or transfer all of its rights or obligations under this Agreement to any affiliate registered in the European Union or which is also carrying
on <FONT STYLE="white-space:nowrap">EU-regulated</FONT> services (in each case, the &#147;<B><U>EU Affiliate</U></B>&#148;) by notice in writing, and from the date of such transfer, references to such Underwriter shall be read as references to such
EU Affiliate. Upon completion of such assignment or transfer of all rights and obligations under this Agreement, each transferor pursuant to this Section&nbsp;14 shall be released from its obligations under this letter agreement. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>No Fiduciary Duty. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The Issuers and the Guarantor hereby acknowledge that (a)&nbsp;the purchase and sale of the Securities pursuant to this Agreement is an <FONT
STYLE="white-space:nowrap">arm&#146;s-length</FONT> commercial transaction between the Issuers and the Guarantor, on the one hand, and the Underwriters and any affiliate through which they may be acting, on the other, (b)&nbsp;the Underwriters are
acting as principal and not as an agent or fiduciary of the Issuers and the Guarantor and (c)&nbsp;the engagement of the Underwriters by the Issuers and the Guarantor in connection with the offering and the process leading up to the offering is as
independent contractors and not in any other capacity. Furthermore, each of the Issuers and the Guarantor agrees that it is solely responsible for making its own judgments in connection with the offering (irrespective of whether any of the
Underwriters has advised or is currently advising the Issuers or the Guarantor on related or other matters). Each of the Issuers and the Guarantor agrees that it will not claim that the Underwriters have rendered advisory services of any nature or
respect, or owe an agency, fiduciary or similar duty to the Issuers and the Guarantor, in connection with such transaction or the process leading thereto. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I><FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding and to the exclusion of any other term of this Agreement or any other agreement, arrangement, or
understanding between or among the Issuers and the Guarantors and an Underwriter incorporated in the EU (the &#147;<B><U>Relevant BRRD Party</U></B>&#148;), the Issuers and the Guarantor acknowledge and accept that a BRRD Liability arising under
this Agreement may be subject to the exercise of <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant Resolution Authority, and acknowledges, accepts and agrees to be bound by: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the effect of the exercise of <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant Resolution Authority
in relation to any BRRD Liability of the Relevant BRRD Party to the Issuers or the Guarantor, as applicable, under this Agreement, that (without limitation) may include and result in any of the following, or some combination thereof: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the reduction of all, or a portion, of the BRRD Liability or outstanding amounts due thereon;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the conversion of all, or a portion, of the BRRD Liability into shares, other securities or other obligations
of the Relevant BRRD Party or another person, and the issue to or conferral on the Issuers or the Guarantor of such shares, securities or obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cancellation of the BRRD Liability; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the amendment or alteration of any interest, if applicable, thereon or the dates on which any payments are due,
including by suspending payment for a temporary period; and </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the variation of the terms of this
Agreement, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise of <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant Resolution Authority. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) For purposes of this Section&nbsp;16(a): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><U><FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation</U></B>&#148; means in relation to a
member state of the European Economic Area which has implemented, or which at any time implements, the BRRD, the relevant implementing law, regulation, rule or requirement as described in the EU <FONT STYLE="white-space:nowrap">Bail-in</FONT>
Legislation Schedule from time to time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><U><FONT STYLE="white-space:nowrap">Bail-in</FONT></U></B><B><U> </U></B><B><U>Powers</U></B>&#148;
means any Write-down and Conversion Powers as defined in the EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation Schedule, in relation to the relevant <FONT STYLE="white-space:nowrap">Bail-In</FONT> Legislation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><U>BRRD</U></B>&#148; means Directive 2014/59/EU establishing a framework for the recovery and
resolution of credit institutions and investment firms, as amended or superseded; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><U>BRRD</U></B><B><U> </U></B><B><U>Liability</U></B>&#148; means a liability in respect of which the
relevant Write-down and Conversion Powers in the applicable <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation may be exercised; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><U>EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation Schedule</U></B>&#148; means the
document described as such, then in effect, and published by the Loan Market Association (or any successor person) from time to time at http://www.lma.eu.com/pages.aspx?p=499; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><U>Relevant</U></B><B><U> </U></B><B><U>Resolution</U></B><B><U> </U></B><B><U>Authority</U></B>&#148;
means the resolution authority with the ability to exercise any <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers in relation to the Relevant BRRD Party. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding and to the exclusion of any other term of this
Agreement or any other agreement, arrangement, or understanding between or among the Issuers and the Guarantor and an Underwriter incorporated in the UK (the &#147;<B><U>Relevant <FONT STYLE="white-space:nowrap">Bail-in</FONT> Party</U></B>&#148;),
the Issuers and the Guarantor acknowledge and accept that a UK Bail-in Liability arising under this Agreement may be subject to the exercise of UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant UK Resolution Authority, and
acknowledges, accepts and agrees to be bound by: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the effect of the exercise of UK
<FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant UK Resolution Authority in relation to any UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability of any Relevant <FONT STYLE="white-space:nowrap">Bail-in</FONT> Party to
the Company under this Agreement, that (without limitation) may include and result in any of the following, or some combination thereof: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the reduction of all, or a portion, of the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability or
outstanding amounts due thereon; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the conversion of all, or a portion, of the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability into
shares, other securities or other obligations of the Relevant <FONT STYLE="white-space:nowrap">Bail-in</FONT> Party or another person, and the issue to or conferral on the Issuers or the Guarantor of such shares, securities or obligations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cancellation of the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the amendment or alteration of any interest, if applicable, thereon or the dates on which any payments are due,
including by suspending payment for a temporary period; and </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the variation of the terms of this
Agreement, as deemed necessary by the Relevant UK Resolution Authority, to give effect to the exercise of UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant UK Resolution Authority. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) For purposes of this Section&nbsp;16(b): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><U>Relevant</U></B><B><U> </U></B><B><U>UK</U></B><B><U> </U></B><B><U>Resolution</U></B><B><U>
</U></B><B><U>Authority</U></B>&#148; means the resolution authority with the ability to exercise any UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers in relation to any Relevant <FONT STYLE="white-space:nowrap">Bail-in</FONT> Party;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><U>UK</U></B><B><U> </U></B><B><U><FONT STYLE="white-space:nowrap">Bail-in</FONT></U></B><B><U>
</U></B><B><U>Legislation</U></B>&#148; means Part I of the UK Banking Act 2009 and any other law or regulation applicable in the UK relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their
affiliates (otherwise than through liquidation, administration or other insolvency proceedings); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><U>UK</U></B><B><U> </U></B><B><U><FONT STYLE="white-space:nowrap">Bail-in</FONT></U></B><B><U>
</U></B><B><U>Liability</U></B>&#148; means a liability in respect of which the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers may be exercised; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><U>UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers</U></B>&#148; means the powers under the
UK <FONT STYLE="white-space:nowrap">Bail-In</FONT> Legislation to cancel, transfer or dilute shares issued by a person that is a bank or investment firm or affiliate of a bank or investment firm, to cancel, reduce, modify or change the form of a
liability of such a person or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or
instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The provisions of this Section&nbsp;16 shall remain in full force and
effect notwithstanding completion and shall survive the termination or cancellation of this Agreement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Jurisdiction. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each of the Issuers and the Guarantor agrees that any suit, action or proceeding against the Issuers or the Guarantor brought
by any Underwriter, the directors, officers, employees, agents and affiliates of any Underwriter, or by any person who controls any Underwriter, arising out of or based upon this Agreement or the offer and sale of the Securities contemplated hereby
may be instituted in any State or Federal court in The City of New York, New York, and waives any objection which it may now or hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of such courts in any suit, action or proceeding. Each of the Issuers and the Guarantor has appointed Teva Pharmaceuticals USA, Inc. (&#147;<B><U>Teva USA</U></B>&#148;) as its authorized
agent (the &#147;<B><U>Authorized Agent</U></B>&#148;) upon whom process may be served in any suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated herein which may be instituted in any State or
Federal court in The City of New York, New York, by any Underwriter, the directors, officers, employees, agents and affiliates of any Underwriter, or by any person who controls any Underwriter, and expressly accepts the <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of any such court in respect of any such suit, action or proceeding. Each of the Issuers and the Guarantor hereby represents and warrants that the Authorized Agent has accepted such
appointment and has agreed to act as said agent for service of process, and each of the Issuers and the Guarantor agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in
full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Issuers or the Guarantor, as applicable. Notwithstanding the foregoing, any action arising out
of or based upon this Agreement may be instituted by any Underwriter, the directors, officers, employees, agents and affiliates of any Underwriter, or by any person who controls any Underwriter, in any court of competent jurisdiction in Israel. EACH
OF THE ISSUERS, THE GUARANTOR AND EACH OF THE UNDERWRITERS HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE
OFFER AND SALE OF THE SECURITIES CONTEMPLATED HEREBY. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Applicable Law. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">This Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be
performed within the State of New York. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Currency. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Each reference in this Agreement to U.S. dollars (the &#147;<B><U>relevant</U></B><B> </B><B><U>currency</U></B>&#148;) is of the essence. To
the fullest extent permitted by law, the obligations of each of the Issuers and the Guarantor in respect of any amount due under this Agreement will, notwithstanding any payment in any other currency (whether pursuant to a judgment or otherwise), be
discharged only to the extent of the amount in the relevant currency that the party entitled to receive such payment may, in accordance with its normal procedures, purchase with the sum paid in such other currency (after any premium and costs of
exchange) on the Business Day immediately following the day on which such party receives such payment. If the amount in the relevant currency that may be so purchased for any reason falls short of the amount originally due, the Issuers and the
Guarantor will pay such additional amounts, in the relevant currency, as may be necessary to compensate for the shortfall. Any obligation of each of the Issuers or the Guarantor not discharged by such payment will, to the fullest extent permitted by
applicable law, be due as a separate and independent obligation and, until discharged as provided herein, will continue in full force and effect. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Recognition of the U.S. Special Resolution Regimes</I></B><B></B><B><I>.</I></B><B>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) In the event that any Underwriter that is a Covered Entity (as defined below) becomes subject
to a proceeding under a U.S. Special Resolution Regime (as defined below), the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would
be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate (as defined below) of such Underwriter
becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights (as defined below) under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights
could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) For purposes of this Section&nbsp;20: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) &#147;<B><U>BHC Act Affiliate</U></B>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be
interpreted in accordance with, 12 U.S.C. &#167; 1841(k); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) &#147;<B><U>Covered Entity</U></B>&#148; means any of the following:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
252.82(b), </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
47.3(b), or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
382.2(b); </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) &#147;<B><U>Default Right</U></B>&#148; has the meaning assigned to that term in, and
shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)
&#147;<B><U>U.S. Special Resolution Regime</U></B>&#148; means each of: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:22%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Federal Deposit Insurance Act and the
regulations promulgated thereunder, and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:22%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act
and the regulations promulgated thereunder. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>21.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Waiver of Immunity. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">To the extent that either of the Issuers or the Guarantor has or hereafter may acquire any immunity (sovereign or otherwise) from any legal
action, suit or proceeding, from jurisdiction of any court or from <FONT STYLE="white-space:nowrap">set-off</FONT> or any legal process (whether service or notice, attachment in aid or otherwise) with respect to itself or any of its property, each
of the Issuers and the Guarantor hereby irrevocably waives and agrees not to plead or claim such immunity in respect of its obligations under this Agreement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>22.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Definitions.</I></B><B></B><B><I> </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The terms which follow, as used in this Agreement, have the meanings indicated: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Base</U></B><B><U> </U></B><B><U>Prospectus</U></B>&#148; means the prospectus contained in the Registration Statement at the
Effective Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Business</U></B><B><U> </U></B><B><U>Day</U></B>&#148; means any day on which the New York Stock Exchange is
open for trading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Disclosure Package</U></B>&#148; shall mean (i)&nbsp;the Base Prospectus, as
amended and supplemented by the Preliminary Prospectus prior to the Execution Time, (ii)&nbsp;the Issuer Free Writing Prospectuses, if any, identified in Schedule II hereto, and (iii)&nbsp;any other Free Writing Prospectus that the parties hereto
shall hereafter expressly agree in writing to treat as part of the Disclosure Package other than a road show that is an Issuer Free Writing Prospectus under Rule 433 of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Effective</U></B><B><U> </U></B><B><U>Time</U></B>&#148; means each date and time that the Registration Statement and any post-
effective amendment or amendments thereto became or becomes effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Execution Time</U></B>&#148; means (i)&nbsp;2:19 P.M.
(New York time) on May&nbsp;20, 2025 for the Euro Securities, (ii)&nbsp;2:21 P.M. (New York time) on May&nbsp;20, 2025 for the 2032 Dollar Securities and (iii)&nbsp;2:23 P.M. (New York time) on May&nbsp;20, 2025 for the 2030 Dollar Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Free</U></B><B><U> </U></B><B><U>Writing</U></B><B><U> </U></B><B><U>Prospectus</U></B>&#148; shall mean a free writing
prospectus, as defined in Rule 405 of the Rules and Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Incorporated</U></B><B><U>
</U></B><B><U>Documents</U></B>&#148; means documents that are incorporated into any of the Registration Statement, Prospectus or Preliminary Prospectus by reference. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Issuer</U></B><B><U> </U></B><B><U>Free</U></B><B><U> </U></B><B><U>Writing</U></B><B><U> </U></B><B><U>Prospectus</U></B>&#148;
shall mean an issuer free writing prospectus, as defined in Rule 433 of the Rules and Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Ordinary</U></B><B><U>
</U></B><B><U>Shares</U></B>&#148; shall mean fully paid, nonassessable ordinary shares of the Guarantor, par value NIS 0.10 per share, or American Depository Shares representing such ordinary shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Preliminary Prospectus</U></B>&#148; shall mean any preliminary prospectus supplement to the Base Prospectus which describes the
Securities and the offering thereof and is used prior to filing of the final Prospectus, together with the Base Prospectus and any Incorporated Documents with respect thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Prospectus</U></B>&#148; means the prospectus and prospectus supplements first filed after the Execution Time with the Commission
by the Issuers and the Guarantor with the consent of the Representatives pursuant to Rule 424(b) of the Rules and Regulations relating to the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>Registration</U></B><B><U> </U></B><B><U>Statement</U></B>&#148; means the Registration Statement of the Issuers and the Guarantor
filed with the Commission on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-284770),</FONT> including any prospectus supplement relating to the Securities that is filed with the Commission
pursuant to Rule 424(b) of the Rules and Regulations and deemed part of such registration statement pursuant to Rule 430B of the Rules and Regulations, exhibits other than Forms <FONT STYLE="white-space:nowrap">T-1</FONT> and financial statements,
as amended at the Execution Time and, in the event any post-effective amendment thereto becomes effective prior to the Delivery Date, means also such registration statement as so amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;<B><U>subsidiary</U></B>&#148; has the meaning set forth in Rule 405 of the Rules and
Regulations. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>23.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Compliance with USA Patriot Act. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Each of the Issuers and the Guarantor acknowledge that, in accordance with the requirements of Title III of the Uniting and Strengthening
America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (Pub. L <FONT STYLE="white-space:nowrap">107-56)</FONT> (USA PATRIOT Act) (signed into law October&nbsp;26, 2001), the Underwriters are required to
obtain, verify and record information that identifies their respective clients, including the Issuers and the Guarantor, which information may include the name and address of their respective clients, as well as other information that will allow the
Underwriters to properly identify their respective clients. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>24.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Counterparts. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">This Agreement may be executed in one or more counterparts and, if executed in more than one counterpart, the executed counterparts shall each
be deemed to be an original but all such counterparts shall together constitute one and the same instrument. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>25.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Headings. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the meaning or
interpretation of, this Agreement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>26.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Electronic Signatures.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">This Agreement may be in the form of an Electronic Record and may be executed using Electronic Signatures (including, without limitation,
facsimile and .pdf) and shall be considered an original, and shall have the same legal effect, validity and enforceability as a paper record. This Agreement may be executed by one or more parties to this Agreement in any number of separate
counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same instrument and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes to the fullest extent permitted by applicable law. For the avoidance of doubt, the authorization under this Section&nbsp;26&nbsp;may include, without limitation, a manually signed paper communication which
has been converted into electronic form (such as scanned into PDF format), or an electronically signed communication converted into another format, for transmission, delivery and/or retention. For the avoidance of doubt, the foregoing also applies
to any amendment, extension or renewal of this Agreement. Each of the parties represents and warrants to the other party/ies that it has the corporate capacity and authority to execute this Agreement through electronic means and there are no
restrictions for doing so in that party&#146;s constitutive documents. For purposes hereof, &#147;<B><U>Electronic Record</U></B>&#148; and &#147;<B><U>Electronic Signature</U></B>&#148; shall have the meanings assigned to them, respectively, by 15
USC &#167;7006, as it may be amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature pages follow) </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the foregoing correctly sets forth the agreement between the Issuers, the Guarantor and
the Underwriters, please indicate your acceptance in the space provided for that purpose below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Amir Weiss</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amir Weiss</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Senior Vice President and Chief Accounting Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eli Kalif</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eli Kalif</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Vice President and Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Vrhovec</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Vrhovec</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Representative</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen David Harper</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stephen David Harper</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Representative</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Vrhovec</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Vrhovec</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Representative</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen David Harper</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stephen David Harper</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Representative</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL FINANCE NETHERLANDS IV B.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Vrhovec</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Vrhovec</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Representative</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen David Harper</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stephen David Harper</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Representative</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement) </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP PARIBAS</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities Europe SA</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC Continental Europe</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intesa Sanpaolo S.p.A.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan SE</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">as Euro Representatives and Euro Underwriters</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BNP PARIBAS</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Giulio Baratta</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Giulio Baratta</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Isla Fletcher</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Isla Fletcher</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BOFA SECURITIES EUROPE SA</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fabian Ansorg</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Fabian Ansorg</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">HSBC CONTINENTAL EUROPE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ J&eacute;r&ocirc;me Pellet</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">J&eacute;r&ocirc;me Pellet</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director Debt Capital Markets</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ J&eacute;r&ocirc;me Zecchini</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">J&eacute;r&ocirc;me Zecchini</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director Debt Capital Markets</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">INTESA SANPAOLO S.P.A.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gianmario Pirolli</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Gianmario Pirolli</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Head of Corporate DCM</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Raffaella Del Maschio</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Raffaella Del Maschio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement) </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ales Mydlar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Ales Mydlar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Quentin Plessis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Quentin Plessis</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement) </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BNP Paribas Securities Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BofA Securities, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">HSBC Bank plc</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Intesa Sanpaolo S.p.A.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. Morgan SE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">as 2032 Dollar Representatives and 2032 Dollar Underwriters</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BNP PARIBAS SECURITIES CORP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Roger Kim</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Roger Kim</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BOFA SECURITIES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ William Brenton</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">William Brenton</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">HSBC BANK PLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ S. Riley</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">S. Riley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">INTESA SANPAOLO S.P.A.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gianmario Pirolli</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Gianmario Pirolli</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Head of Corporate DCM</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Raffaella Del Maschio</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Raffaella Del Maschio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ales Mydlar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Ales Mydlar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement) </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Quentin Plessis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Quentin Plessis</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement) </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BNP Paribas Securities Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BofA Securities, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">HSBC Bank plc</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Intesa Sanpaolo S.p.A.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. Morgan SE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">as 2030 Dollar Representatives and 2030 Dollar Underwriters</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BNP PARIBAS SECURITIES CORP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Roger Kim</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Roger Kim</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BOFA SECURITIES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ William Brenton</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">William Brenton</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">HSBC BANK PLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ S. Riley</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">S. Riley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">INTESA SANPAOLO S.P.A.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gianmario Pirolli</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Gianmario Pirolli</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Head of Corporate DCM</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">/s/ Raffaella Del Maschio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Raffaella Del Maschio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ales Mydlar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Ales Mydlar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Quentin Plessis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Quentin Plessis</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement) </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Citigroup Global Markets Europe AG</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Goldman Sachs Bank Europe SE</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Mizuho Bank Europe N.V.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MUFG Securities (Europe) N.V.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PNC Capital Markets LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">as Euro Underwriters</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CITIGROUP GLOBAL MARKETS EUROPE AG</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carlos Vero</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Carlos Vero</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Designated Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stefan Saalmuller</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stefan Saalmuller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GOLDMAN SACHS BANK EUROPE SE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Rene Klos</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Rene Klos</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Philipp Suess</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Philipp Suess</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MIZUHO BANK EUROPE N.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christoph Paul</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Christoph Paul</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Head of EU Primary Markets</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Hyoe Ando</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Hyoe Ando</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Head of CIB, EU</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MUFG SECURITIES (EUROPE) N.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sophie Horreard</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Sophie Horreard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PNC CAPITAL MARKETS LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ William Bobrow</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">William Bobrow</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement) </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Citigroup Global Markets Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Goldman Sachs Bank Europe SE</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Mizuho Securities USA LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MUFG Securities Americas Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PNC Capital Markets LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">as 2032 Dollar Underwriters</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CITIGROUP GLOBAL MARKETS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam D. Bordner</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Adam D. Bordner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GOLDMAN SACHS BANK EUROPE SE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Rene Klos</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Rene Klos</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Philipp Suess</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Philipp Suess</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MIZUHO SECURITIES USA LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Seth Nadler</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Seth Nadler</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MUFG SECURITIES AMERICAS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Grant Moyer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Grant Moyer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PNC CAPITAL MARKETS LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ William Bobrow</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">William Bobrow</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement) </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Citigroup Global Markets Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Goldman Sachs Bank Europe SE</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Mizuho Securities USA LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MUFG Securities Americas Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PNC Capital Markets LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">as 2030 Dollar Underwriters</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CITIGROUP GLOBAL MARKETS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam D. Bordner</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Adam D. Bordner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GOLDMAN SACHS BANK EUROPE SE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Rene Klos</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Rene Klos</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Philipp Suess</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Philipp Suess</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MIZUHO SECURITIES USA LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Seth Nadler</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Seth Nadler</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MUFG SECURITIES AMERICAS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Grant Moyer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Grant Moyer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PNC CAPITAL MARKETS LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ William Bobrow</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">William Bobrow</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement) </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OPINION OF KIRKLAND&nbsp;&amp; ELLIS LLP </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OPINION OF VAN DOORNE N.V. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OPINION OF AGMON WITH TULCHINSKY LAW FIRM </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OPINION OF GENERAL COUNSEL OF THE GUARANTOR </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE I </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Part A </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Euro Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of</B><br><B>Euro Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP PARIBAS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES EUROPE SA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC CONTINENTAL EUROPE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INTESA SANPAOLO S.P.A.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CITIGROUP GLOBAL MARKETS EUROPE AG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS BANK EUROPE SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MIZUHO BANK EUROPE N.V.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG SECURITIES (EUROPE) N.V.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC CAPITAL MARKETS LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Part B </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>2032 Dollar Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of</B><br><B>2032 Dollar Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP PARIBAS SECURITIES CORP.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES, INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC BANK PLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INTESA SANPAOLO S.P.A.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SE.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CITIGROUP GLOBAL MARKETS INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS BANK EUROPE SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MIZUHO SECURITIES USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG SECURITIES AMERICAS INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC CAPITAL MARKETS LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Part C </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>2030 Dollar Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of</B><br><B>2030 Dollar Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP PARIBAS SECURITIES CORP.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES, INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC BANK PLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INTESA SANPAOLO S.P.A.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SE.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CITIGROUP GLOBAL MARKETS INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS BANK EUROPE SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MIZUHO SECURITIES USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG SECURITIES AMERICAS INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC CAPITAL MARKETS LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">700,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Final Term Sheet dated May&nbsp;20, 2025 as filed with the Commission pursuant to Rule 433 of the Rules and Regulations. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d929611dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle">


<IMG SRC="g929611g0521002850030.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g929611g0521002849068.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Proceeds to Repay Existing Debt </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TEL AVIV, Israel&#151;(BUSINESS WIRE)&#151;<B> </B>Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (&#147;<B>Teva</B>&#148;) announced today that it
successfully upsized its offering and priced approximately $2,300,000,000 (equivalent) of its senior notes (the &#147;<B>Notes</B>&#148;). The principal amount of the offering was increased from the previously announced offering size of
$2,000,000,000 (equivalent). Teva expects to use the net proceeds from the offerings (i)&nbsp;to fund the announced tender offers (collectively, the &#147;<B>Tender Offer</B>&#148;) to purchase, for cash, its 3.150% Senior Notes due 2026, 4.750%
Sustainability-Linked Senior Notes due 2027, 3.750% Sustainability-Linked Senior Notes due 2027, 7.875% Sustainability-Linked Senior Notes due 2029, 7.375% Sustainability-Linked Senior Notes due 2029 and 8.125% Sustainability-Linked Senior Notes due
2031 (as it may be amended prior to expiration thereof), (ii) to pay fees and expenses in connection therewith and (iii)&nbsp;to the extent of any remaining proceeds, the repayment of outstanding debt upon maturity, tender offer or earlier
redemption. Net proceeds may be temporarily invested pending application for their stated purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes consist of (i)&nbsp;Teva Pharmaceutical
Finance Netherlands II B.V&#146;s (&#147;<B>Teva Finance II</B>&#148;) &#128;1,000,000,000 aggregate principal amount of 4.125% <FONT STYLE="white-space:nowrap">EUR-denominated</FONT> Senior Notes maturing in 2031, (ii) Teva Pharmaceutical Finance
Netherlands III B.V.&#146;s (<B>&#147;Teva Finance III</B>&#148;) $500,000,000 aggregate principal amount of 6.000% <FONT STYLE="white-space:nowrap">USD-denominated</FONT> Senior Notes maturing in 2032 and (iii)&nbsp;Teva Pharmaceutical Finance
Netherlands IV B.V.&#146;s (&#147;<B>Teva Finance IV</B>&#148; and, together with Teva Finance II and Teva Finance III, the &#147;<B>Issuers</B>&#148;) $700,000,000 aggregate principal amount of 5.750%
<FONT STYLE="white-space:nowrap">USD-denominated</FONT> Senior Notes maturing in 2030. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The settlement of the Notes is expected to occur on or about
May&nbsp;28, 2025, subject to customary closing conditions. The settlement of the Notes will satisfy the financing condition to the Tender Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Notes will be unsecured senior obligations of the Issuers and will be unconditionally guaranteed on a senior unsecured basis by Teva. The offering and sale of the Notes were made pursuant to our effective automatic shelf registration statement on
Form <FONT STYLE="white-space:nowrap">S-3,</FONT> including our base prospectus, filed with the Securities and Exchange Commission (the &#147;<B>SEC</B>&#148;) on February&nbsp;7, 2025. The offering of these Notes was made only by means of a
prospectus supplement and accompanying base prospectus, which have been filed with the SEC. Before you invest, you should read the prospectus supplement and accompanying prospectus along with other documents that Teva has filed with the SEC and that
are incorporated by reference into the prospectus supplement and accompanying base prospectus for more complete information about Teva and this offering. These documents are available at no charge by visiting EDGAR on the SEC website at
http://www.sec.gov. Alternatively, a copy of the prospectus supplement and accompanying base prospectus related to this offering may be obtained, when available, by contacting BNP PARIBAS, 16, boulevard des Italiens, 75009 Paris, France, Attention:
High Yield Desk (email: dl.syndsupportbonds@uk.bnpparibas.com); BNP Paribas Securities Corp., 787 Seventh Avenue, New York, New York 10019, United States of America, Attention: Syndicate Desk </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(email: <U>DL.US.Debt.Syndicate.Support@us.bnpparibas.com</U>); BofA Securities Europe SA, 51 rue La Bo&eacute;tie, 75008 Paris, France, Attention: High Yield Syndicate Desk (Tel: +33 18 770
0000, email: <U>levfin_hy_paris@bofa.com</U>); BofA Securities, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">NC1-004-03-43,</FONT></FONT></FONT> 200 North College Street, 3<SUP
STYLE="font-size:75%; vertical-align:top">rd</SUP> Floor, Charlotte NC 28255-0001, Attention: Prospectus Department, or by email: at dg.prospectus_requests@bofa.com; HSBC Continental Europe, 38, avenue Kl&eacute;ber, 75116 Paris, France, Attention:
DAJ Global Banking, email: transaction.management@hsbcib.com; HSBC Bank plc, 8 Canada Square, London E14 5HQ, United Kingdom, Attention: Head of DCM Legal, email: transaction.management@hsbcib.com; Intesa Sanpaolo S.p.A., Divisione IMI
Corporate&nbsp;&amp; Investment Banking, Via Manzoni, 4 &#150; 20121, Milan, Italy, Attention: DCM HY Intesa Sanpaolo, email: <FONT STYLE="white-space:nowrap">IMI-DCM.HY@intesasanpaolo.com;</FONT> or J.P. Morgan SE, Taunustor 1 (TaunusTurm), 60310
Frankfurt am Main, Germany, Attention: Head of EMEA Capital Markets Group, email: Head_of_EMEA_DCMG@jpmorgan.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute
an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the
securities laws of any such jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Teva </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of
innovation to reliably deliver medicines to patients worldwide. For over 120 years, Teva&#146;s commitment to bettering health has never wavered. Today, the company&#146;s global network of capabilities enables its 37,000 employees across 57 markets
to advance health by developing medicines for the future while championing the production of generics and biologics. We are dedicated to addressing patients&#146; needs, now and in the future. Moving forward together with science that treats,
inspired by the people we serve. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Note Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on
management&#146;s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or
implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: completion of the offering of senior notes and tender offer for certain outstanding notes; our substantial
indebtedness, which may limit our ability to incur additional indebtedness, engage in additional transactions or make new investments, and may result in a further downgrade of our credit ratings; our inability to raise debt or borrow funds in
amounts or on terms that are favorable to us; and other factors discussed in our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the first quarter of 2025, our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2024, including the sections thereof captioned &#147;Risk Factors&#148; and &#147;Forward Looking Statements,&#148; and other filings with the SEC, which are available
at www.sec.gov. Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new
information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements. No assurance can be given that the transactions described herein will be consummated or as to the ultimate terms of any such
transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It may be unlawful to distribute this press release in certain jurisdictions. This press release is not for
distribution in Canada, Japan or Australia. The information in this press release does not constitute an offer of securities for sale in Canada, Japan or Australia. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail
investor in the European Economic Area (&#147;<B>EEA</B>&#148;). For these purposes, a retail investor means a person who is one (or more) of: (i)&nbsp;a retail client as defined in point (11)&nbsp;of Article 4(1) of Directive 2014/65/EU (as
amended, &#147;<B>MiFID II</B>&#148;); or (ii)&nbsp;a customer within the meaning of Directive 2016/97/EU (as amended, the &#147;<B>Insurance Distribution Directive</B>&#148;), where that customer would not qualify as a professional client as
defined in point (10)&nbsp;of Article 4(1) of MiFID II; or (iii)&nbsp;not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129. Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the
&#147;<B>PRIIPs Regulation</B>&#148;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail
investor in the EEA may be unlawful under the PRIIPs Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are not intended to be offered, sold or otherwise made available to and should
not be offered, sold or otherwise made available to any retail investors in the United Kingdom. For these purposes, a retail investor means a person who is one (or more) of the following persons: (i)&nbsp;a retail client as defined in point
(8)&nbsp;of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (&#147;<B>EUWA</B>&#148;); or (ii)&nbsp;a customer within the meaning of the provisions of the Financial
Services and Markets Act 2000 as amended (the &#147;<B>FSMA</B>&#148;) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point
(8)&nbsp;of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA; or (iii)&nbsp;not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of
the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the &#147;<B>UK PRIIPs Regulation</B>&#148;) for offering or selling the Notes or otherwise making
them available to retail investors in the United Kingdom has been prepared and, therefore, offering or selling the Notes or otherwise making them available to any retail investor in the United Kingdom may be unlawful under the UK PRIIPs Regulation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Promotion of the Notes in the United Kingdom is restricted by the FSMA, and accordingly, the Notes are not being promoted to the general public in the
United Kingdom. This announcement is for distribution only to, and is only directed at, persons who (i)&nbsp;persons who are outside the United Kingdom or (ii)&nbsp;investment professionals falling within Article 19(5) of the Financial Services and
Markets Act 2000 (Financial Promotion) Order 2005 (the &#147;<B>Order</B>&#148;), (iii) high net worth entities, and other persons to whom they may lawfully be communicated, falling within Article 49(2)(a) to (d)&nbsp;of the Order or
(iv)&nbsp;persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) in connection with the issue or sale of any notes may otherwise lawfully be communicated or caused to be
communicated (all such persons together being referred to as &#147;<B>relevant persons</B>&#148;). The Notes will only be available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such Notes will be engaged in
only with, relevant persons. This announcement is directed only at relevant persons and must not be acted on or relied on by anyone who is not a relevant person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes have not, may not and will not be offered, sold or delivered in the Netherlands, other than to
qualified investors (as defined in Regulation (EU) 2017/1129). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes have not, may not and will not be offered, sold or delivered in Israel, other
than to persons who qualify as one of the types of investors listed in the First Addendum to the Israeli Securities Law, subject to and in accordance with the requirements set forth in the First Addendum to the Israeli Securities Law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Teva Media Inquiries: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>TevaCommunicationsNorthAmerica@tevapharm.com </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Teva
Investor Relations Inquires </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>TevaIR@Tevapharm.com </U></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>teva-20250520.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 5/23/2025 12:10:33 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:teva="http://imetrix.edgar-online.com/20250520"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://imetrix.edgar-online.com/20250520"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20250520_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20250520_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>teva-20250520_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 5/23/2025 12:10:33 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>teva-20250520_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 5/23/2025 12:10:33 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="teva-20250520.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g929611g0521002849068.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g929611g0521002849068.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #' ,P# 2(  A$! Q$!_\0
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M.IHIU(T1Z)1117T1VA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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(4[7,ZBN?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g929611g0521002850030.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g929611g0521002850030.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !" )P# 2(  A$! Q$!_\0
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MR3W$3 *K9SQ7SCJ5E-I6K36TJE9(9".1Z&IPNB:96*U::-"/4/$J1JL<]\$
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M+/>64L,?DD;G7 S7LM%1+$RE%Q:+CAHQDI)A24M)7.= 4444 %%%% !1110
>4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TEVA PHARMACEUTICAL INDUSTRIES LTD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 20,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">124 Dvora HaNevi&#8217;a Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6944020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3-914-8213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">American Depositary Shares, each representing one Ordinary Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TEVA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d929611d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d929611d8k.htm">d929611d8k.htm</File>
    <File>teva-20250520.xsd</File>
    <File>teva-20250520_lab.xml</File>
    <File>teva-20250520_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d929611d8k.htm": {
   "nsprefix": "teva",
   "nsuri": "http://imetrix.edgar-online.com/20250520",
   "dts": {
    "inline": {
     "local": [
      "d929611d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "teva-20250520.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "teva-20250520_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "teva-20250520_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-05-20_to_2025-05-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d929611d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-05-20_to_2025-05-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d929611d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://imetrix.edgar-online.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-25-125071-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-125071-xbrl.zip
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M/ACBVZ6Q;2ACJWJ1'$NA\B41Y)[Z$K,CC)8XL59OOH_K;13)32Q<Z11(&L7
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M?FU$,YL%1V0>;#VG*UE@7>,N&-!=BKWR!6NQQ4S+6A;LHG\M7>->2]S['53
MSY:1]SZ_V%7$O=>_=GD!8O^Z]A[O^,[8<*G]6]\Q*M9!=,Z8]\W>2F3=+;^_
M+?VFW[N>.6T=H)\]=2L]RYQL;836N]7Y)L^+F)/[_ '-5ZR=ZM;D#; FL)1
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M_:L9^C"MK\O3B$4WGC'O%[TPD(0=4'LG\SAAW@P6L$K=B\TN6?+Q $B8MCC
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M0K9KQL!>8)5+/:GHA D>WY9F<X(\5:[^!D6T,I([[!MY_K_!-P(_.=Y]]^%
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MYUR;0,=)MZS>>^#ON@[\;_? MQ8=>,TN;3MP[S@+#GQKX8'[GKC.@;>LMOW
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M E,Q8^V3W9"#F]'[ VZ#CIJ;(-'8[UBLQ>*&0/L%<HXQH5[W>S8,0XZH ZG
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M+R.KK9$4S.G-R^S@BB*[]="O)KG_ZVF+R$;X"K_,;LS@BJ([6%YR+W>V=U:
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M"]@EWO)Z3+C91EA5-UMV" F0.E(_7L!D.ILHT"(_,C]V3U).3O&$JIO2U:S
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M.(]HB(9#6L[F52+M1PH*59[@C[,I)X)S6#&4Z#Z9&J,B272RM.Y![W0)DKQ
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MB3^?P#3P*S09,LQ G%CJN\1"BY3M,WJ#;0UHJ\/,IKE%Y!>(R?>,X?G:)%
MT&O<IG(:'=;H#UJ]*!OFSK56@9(8724@Q'A/,G10JE2(&S\67-IG;&*PBR@^
MP=$(9 VH;L&A%'V15Z]TW7HWO[Y2?!6RRS=.>GJ1@6^-K^&*+X6^L*+9.<E)
M_LNA3?_VC<TE\%"CW''WP2&TZ$W>KW+A!9,2%YR%LM*WMS:W_J&Q\JY/8Z(C
M:!>V=VO$D<X![IN^54L<*:554A;MMK/^[I5S!D[W$2'^'A^"9^?[/9= 7->F
M!3WNMHW:5/D$IEIJ&OU(I_-I*;#">)28YKN:2R)X&)C8R2XWM2Z\/YYL\,8
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M]WDX0U=^%L U@1P; -VB7/)\"BMX DV, VF"?8IG.M]^$TZEX*<Z\/HS-;W
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M!*;8L'0:JP$UJUJ8*%(@#7@]W%A6GM,0JD<>Q,-*3+!J2FCWHUE-WNJCG%F
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M4FDO1'SHE:XEZD4>43I4AM9?F-8/,T[K&[(<$AF!"%V-K@VM=1RC,>O?D0M
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M#Q#:P<#A\Z]?"9!SK0%W3P?PX[K$P8"O K\+?33XJ(5Z97$BL$>NX+180",
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MD-:A5JC*\KIH2/FP\DB%H#<Y60Z1 H>12)>).;N^$3>=V_Y99^"(%HH$<"P
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M2VIU_^NJ%_WN(,-T?V&4J;JIIP..4T0<YX5#CEB..$OX/!]\GN)<@XJ[OS<
MW>AH&I7[@_9*Y9/8^U2!4*[F)D4;GKR!D]\GXF9X]DN#:F0;*GO]"P=F%XN4
M&3; Y&?I,("BF8/KM>5PPR56]B,'5FS?U#:5XHH[,DEDT.% 0_,@=DXD^L3)
M8@M'HCR\E!\2MM3M]#WU% LJWKOH.U;<%Q"31I&L3\^<0>MP?7=CQ8>+L@NG
MNZI+/GR]6)E+:T.\TZ0Y6+"[9(+\HI(\L_<2$[JN0K\MF?,%#II4F\9YT2S+
M^ #1@!53T\/B%BYK:[ P39?I- W-!,AYCM*=P_7VQKKD7S2L>X6_)DP-YE08
MK_N/2Q+(3I94^3Z6)KI^Z*56\/0+BKP]7!(!]70>J6V[_G0HM4U'T6[E(H#J
M;BS]MB)O%/IT%38?)ML64FBO/R]*;N$YYG#GGEKX-I>KURIOUVD"SKW\@G@[
M!#.6PG<8M1VSQ86 J0GP2",#NV_E1TVE:[_FJF@US7/R8%^PV"E^V2''6N6,
MI@8_]]Z<_"=!59\H70XOAI#J?6,C)(_[Y(P'L=81R^@_8]NYU9HN:[*RSS3Z
MD55D#0!IEYOLA4<P^#+D"PB4<=KDTP3P)6C_N8W [?\V K^W #-&S7>@\=%A
M\V8MR2[!/U=+V9L&*I]NEWXGXEB?BN27.OSUVFK*&'.M7DH:G\T3-WYD)?J]
MC# _/+7T4^[&#*A$WE+F3Y9IW7&RF)G+M 6# I]_+V;9>\'CK([GH:))IUD&
M8<[S*Y-J.:_\PL->0# )"O><<C=O\V,[UU&< >/5-YSXZ1[J2]U X%LY5\KS
MI>B'A#I./_HA5PQ.[OGP\SR(46W(MT'MY>?7"5[SU1ZZN2;H+NL/N))!.-5K
M_2SOOE59U6K84_I9^-.(O"1O^K>O[Y[FP7]@9-GY=&0!5]]U/^ A_Z]&_@U0
M2P,$%     @ "8*V6IT(!FA& P  90L  !$   !T979A+3(P,C4P-3(P+GAS
M9+U6WV_;-A!^+]#_X:JG#9A$2ZX+1(A3I$L#!$BSP4V'O16T=':(4J1&4HG]
MW^](28YB)ZZ;%/6+:=Y]=]_]I(_?KRH)MVBLT&H:I<DH E2%+H5:3J/&QMP6
M0D3O3UZ_.GX3QW!V?G$%,=PX5]N<L;N[NZ1<"&6U;!Q9L$FA*P9QW.O_>?T%
M_FFMYS!#B=PB5-PZ-/"A$;+,LU'V-DVS+$F',(/<VX.2.\QAPK(Q(\4)I%F>
MCO+Q&$X_P<=@1L&UJ'"(U?7:B.6-@]^*WR&@SK12*"6NX5PHK@K!)7SN*?\!
M%ZI(X%1*F'F8)9X6S2V626=U9<O<%C=8\=>O "AARN:*3#;5-/*9Z!*QFAN9
M:+-DI3/,K6MDI!23%AI11 /H]W$[&*J$E]@-<,'M/(!ZB<_/VP'"X2W?:%.&
MG!&K!,LE-[%64B@,I?+I&4VRT0!8HMC@ C6+1;+4MXP$VTZ\7#P>3#8:C1EU
MAJ-\XP!"KK_M07CQG)IDZ&0'<C<.@/3HZ(@%Z1:ETCV,H+,^8:TP:'-'&9DW
M#L^UJ<YPP1M)J$;]UW I%@++H$4=6Z%R#W0>:CANENBN>(6VY@4^*^748(_%
M1Y13]N^GR\^A]Z(3#P ([2BJ6AL';5=>ZB),RYZT^E]Q7XW87\5I%H_3A(Q%
MH';8[RDEL!<3Z8O\+"*;#CF8B'VJD_TA]H>GO#_>_\_.P/: ^_B/?/SINX/B
MWUD0/X&)5E<O)3/8<L^OB>*B:)=8>SR\+O?(%_5FOQU\'B9['6^OD\YK\,F5
MTBXX&C+A=2W40G=7=.F;..\[>88+"&LLYZ8P6N+^9<=JHVLT3M#2OQ^&UL"-
MP<4T\KL_[O?,5\GG">V97F7'P</Q\F)&$)27]_1ZK!/.@R^]&+R<7D\N-Z9]
M.TPC2WF7@_'\Q>'6!G\T7()8VO*A;$]'_?= ZX>#]WZN20/\X<OLXOOOQ.:A
M8(ZOM-+5NB5[IHO&OTG]]ZDJ/RJBN+Z@#C-5H!>!H!=E1NI?#U+?D.WIEDC_
MZD1HXW3D/_2GK[<P/')50FL.!O:.V;:1;?N-Q?(O=1+.!9=%(S?)[\"=QC[@
M=MD.1]XS>QK7W?:%Z\>9;<]S=S.<^_:JW3OT\W]02P,$%     @ "8*V6K=F
M&_U1!@  >T,  !4   !T979A+3(P,C4P-3(P7VQA8BYX;6S-G&]OVS80QM\7
MZ'>X>6\VH+)CIWU1HVF1.<D0+&V"Q-V&#4,A2XQ-C"(-4D[L;S]2?QHYIF3)
M/$UYT5:1[IY[3OGQ0EA*/WQ:1PP>B%14\)/>L'_4 \(#$5(^/^FME.>K@-(>
MJ-CGH<\$)R>]#5&]3Q]?O_KP@^?!V<7E%_!@$<=+-1X,'A\?^^$]Y4JP5:PE
M53\0T0 \+X^?3+_"[VFY,=P21GQ%(/)53"3\LJ(L'(^.1F^'P]&H/RRF2>(;
M/0C]F(SAW6!T/-"![V X&@^/QL?'</H9SA,9#E,:D6*N6&XDG2]B^"GX&9*L
M,\$Y88QLX()RGP?49W"76WX#ESSHPREC<&O2E/:IB'P@83]3993_.S9_S8Q[
M>/T*0-]&KI)S)SUS,[)[L9Y)UA=RKLT>'0_RE-Y3QGHGY?$X21B^?_]^D%PM
M1BMJB]7BP\&?GZ_N@@6)?$_??OWM"K(RBHY5<OY*!,D]K&$02B/,5UX>YIE3
MWG#D'0_[:Q7V/IJ"V=WQ9X1=Z2-(>AA+P4A%87,YJ=[+XN/-4L>3=4QX2#+E
M[]HBR*(6DMRGJ@:^1%*1H#\7#X.04$/(6W/@F0/C\$?]Q;>)T+R?SE0L_2#>
MKL?,+1(R/YDT<=*S) VV#9FX4QEL:?DRR'7TX9[^LXA!(/3W;1E[B6*>?B]%
M9'61E1.6B]_8C%EM&I+TD5G>A'M?[_;UF@H5&Y-$B974>#7YUB;]?$R4X>]<
M^Y\/@Z?:+\6J'B&*7#7UZX;D.8]IO+DE<VH*\?B+'Y&Z9-IS.P*TLA%1'N."
M:[D>$K5I 7BJ *:$,[OM^2XBW-0\!LA3?WT9$GUX3],?.5]6T8S(9D27BG2*
M]K[61(U@=]@KA7&IUZ5@NQ:DQ9#X;[45RT(XH!^W)7$:Z2V,_A-?,']>=PD\
M2^H(>;MU8;GH@K1%" GA[\I@I)V!;<%H$="Z;C$F]$27D3Z[U)OK]6]DTVPR
M[R1W.I'+6A$50>X3V"J(.WFS$I#4 %T$:>*V8MTR:1OX=T/Z3 0KLVZFVGU=
MDK=S.@+8:ESL7G/!=5<'B=)<&(RR,YKX-HM$UO2*@^$-D52$YSP\\^/&/#Y+
M[AA,>RNB(@@#58L@-K-I"= UP!1!P[<%ZU:.:_O'V"Q<\D#(I9#);ODNUO4F
M8J5G^V8BPH8?4^R1ZG0C4:]-43O%?9-10QYWR[%5$)**D)4$4Q-I!_(_]&79
MCQS>',8BNJ",'/(Q2#&OT^5A:4#8K[N#_UP+EW*CCOLA!K9?"[VU3&. >AJ&
MVK+*_KFBG R;$6L5Z!3=JI;$GD!WF$M%<:G.]-_D!V JP37'&MJMM6&!_8!>
M$-&?Z,-K.16/_"#PB^DO 7M+.S;HG\+0D'\NV1+PI@P(":80+NS8#52A7J\+
M1,QOA(I]]A==-M_&VQ5> NSVIFR\;T6B(6]1;8GZM!+H4IA;\_;:J&*_=B^8
M4S[=^A\VXO/<EX#\\T:LPSV-P9OL1;VVQGI: WFB8QJO'.?[W#N^Q&1:DL1O
M,KNW<[IZA<EF7.Q><WJ!:4<'"='D9[11QAFY^#ZW7EZJ:=8-1/-6(;M9"-[P
MTXW=O(Z +&U V*^[@&G70H(S$8=$'>O3C7;\%B%M8MH-U#\DC6/")R**5CQ[
M]4/5I;4DN2-DJUL1%4$N\%8((A&<58#M$LX4MVB\B')3]VXXWPE& QI3/O_L
M:Q?49W59MF5V!')%$Z(LP@7A,C4D?I_D(==WAK<MRT5R&_EVP_9&$K,^B,8B
M>=QO7N^7U_?W]3<.50H=85RC*;$OT@7K?:I(>.LR4*P#:2%(*CF#WG831> /
M[ 05_4NE5D2Z+P"+SLM8!N4-VA?#3CSBDBC1;FMAI.5:71\M=52Y2AJUY;B]
M(<%*[Z<VP]%L2F-6^S..W;RNMC9E#0C[=:=MC54+:U.3B8-6AT3>?4_3BM^M
M'4T#TVZ@3J5O?EGV;A/-1.TM^+.DCA"U6Q>6BRYP6H20R,R4(95VIK(%HT4D
MZ[K%F9OGZV"ANR5-?I/0GMOQ_+0V(LIC,.;HKA[V+,TKX/PF87N^K3.UIGF,
M9W7G$9%SO6I^E>(Q7NC-R-+G#1_9E4AT^N2NNBVQ-]3].5Z%+!+KV0.QO!"D
ME2 KA?14K\4V+ _WZO92/'&EC\S_&9&=HNG_G*#/_ =02P,$%     @ "8*V
M6LGW'Z*Y!   =2H  !4   !T979A+3(P,C4P-3(P7W!R92YX;6S5FF]OZC84
MQM]?Z7X'+WNS20LA0+<5E5XQVEZAM;T5<+=I;ZY,<@!KCHUL4^#;[SC@BD#H
MH-N=8E[PQ_%S_/C\'"<VN?JPRCAY!J69%)T@KM4# B*1*1/33K#0(=4)8P'1
MAHJ4<BF@$ZQ!!Q^NW[^[^B8,R<U=_Y&$9&;,7+>C:+E<UM()$UKRA<&0NI;(
M+")AZ.KW1I_);YOFVF0 '*@&DE%M0)%?%HRG[4:]T8KC1J,6[\H44!N/I-1
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M&-0O&O7(T)44,EM'5AO=R&21@3#NLRO26V&86??%1*HL[U% \N2V9PHFG<#
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M   1              "  ?Z_  !D.3(Y-C$Q9&5X.3DQ+FAT;5!+ 0(4 Q0
M   (  F"MEJ=" 9H1@,  &4+   1              "  675  !T979A+3(P
M,C4P-3(P+GAS9%!+ 0(4 Q0    (  F"MEJW9AO]408  'M#   5
M      "  =K8  !T979A+3(P,C4P-3(P7VQA8BYX;6Q02P$"% ,4    "  )
M@K9:R?<?HKD$  !U*@  %0              @ %>WP  =&5V82TR,#(U,#4R
?,%]P<F4N>&UL4$L%!@     &  8 ?@$  $KD      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d929611d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="teva-20250520.xsd" xlink:type="simple"/>
    <context id="duration_2025-05-20_to_2025-05-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818686</identifier>
        </entity>
        <period>
            <startDate>2025-05-20</startDate>
            <endDate>2025-05-20</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2025-05-20_to_2025-05-20"
      id="Hidden_dei_EntityRegistrantName">TEVA PHARMACEUTICAL INDUSTRIES LTD</dei:EntityRegistrantName>
    <dei:EntityTaxIdentificationNumber
      contextRef="duration_2025-05-20_to_2025-05-20"
      id="Hidden_dei_EntityTaxIdentificationNumber">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:AmendmentFlag contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-255">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-05-20_to_2025-05-20"
      id="Hidden_dei_EntityCentralIndexKey">0000818686</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-266">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-267">2025-05-20</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-268">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-269">001-16174</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-270">124 Dvora HaNevi&#x2019;a Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-271">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-272">6944020</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-273">IL</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-274">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-275">3-914-8213</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-276">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-277">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-278">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-279">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-280">American Depositary Shares, each representing one Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-281">TEVA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-282">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-283">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
